Aware (AWRE) 10-K 13 Feb 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Feb. 05, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	AWARE INC /MA/
Entity Central Index Key	1015739
Trading Symbol	awre
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Current Fiscal Year End Date	-19
Entity Filer Category	Accelerated Filer
Entity Well-Known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding		22,865,565
Entity Public Float			$95,635,924
Document Type	10-K
Document Period End Date	31-Dec-14
Amendment Flag	FALSE
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:
Cash and cash equivalents	$43,985	$72,660
Accounts receivable (less allowance for doubtful accounts of $20 at December 31, 2014 and 2013)	3,619	4,582
Inventories	2	1,601
Deferred tax assets	168	383
Prepaid expenses and other current assets	401	695
Total current assets	48,175	79,921
Property and equipment, net	5,289	5,582
Investments	1,428	2,754
Long term deferred tax assets	804	762
Other assets	197	310
Total assets	55,893	89,329
Current liabilities:
Accounts payable	258	1,516
Accrued expenses	108	108
Accrued compensation	585	571
Accrued professional fees	127	118
Deferred revenue	2,352	1,848
Total current liabilities	3,430	4,161
Long-term deferred revenue	74	18
Commitments and contingent liabilities (Note 9)
Stockholders' equity:
Preferred stock, $1.00 par value; 1,000,000 shares authorized, none outstanding
Common stock, $.01 par value; shares authorized, 70,000,000 in 2014 and 2013; issued and outstanding 22,808,761 in 2014 and 22,574,251 in 2013	228	226
Additional paid-in capital	103,756	101,293
Accumulated other comprehensive loss	-29	-125
Accumulated deficit	-51,566	-16,244
Total stockholders' equity	52,389	85,150
Total liabilities and stockholders' equity	$55,893	$89,329

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Statement Of Financial Position [Abstract]
Allowance for doubtful accounts (in dollars)	$20	$20
Preferred stock, par value (in dollars per share)	$1	$1
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares outstanding
Common stock, par value (in dollars per share)	$0.01	$0.01
Common stock, shares authorized	70,000,000	70,000,000
Common stock, shares issued	22,808,761	22,574,251
Common stock, shares outstanding	22,808,761	22,574,251

CONSOLIDATED_STATEMENTS_OF_INC

CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Revenue:
Software licenses	$8,537	$8,241	$9,525
Software maintenance	4,351	3,866	3,038
Services	5,173	3,148	2,571
Hardware	4,933	3,182
Royalties	726	920	2,170
Total revenue	23,720	19,357	17,304
Costs and expenses:
Cost of hardware	3,485	2,365
Cost of services	2,359	1,503	1,542
Research and development	5,505	4,085	3,489
Selling and marketing	3,741	3,344	3,370
General and administrative	3,668	3,522	3,860
Total costs and expenses	18,758	14,819	12,261
Patent related income	2,127	780	87,515
Operating income	7,089	5,318	92,558
Other income (expense)	-59	23	85
Interest income	225	328	227
Income from continuing operations before income taxes	7,255	5,669	92,870
Provision for income taxes	2,672	1,917	20,487
Income from continuing operations	4,583	3,752	72,383
Loss from discontinued operations, net of income taxes		-1,156	-76
Net income	4,583	2,596	72,307
Basic net income per share:
Basic net income per share from continuing operations (in dollars per share)	$0.20	$0.17	$3.32
Basic net loss per share from discontinued operations (in dollars per share)		($0.05)	$0
Basic net income per share (in dollars per share)	$0.20	$0.12	$3.32
Diluted net income per share:
Diluted net income per share from continuing operations (in dollars per share)	$0.20	$0.16	$3.28
Diluted net loss per share from discontinued operations (in dollars per share)		($0.05)	$0
Diluted net income per share (in dollars per share)	$0.20	$0.11	$3.28
Weighted-average shares - basic (in shares)	22,703	22,543	21,814
Weighted-average shares - diluted (in shares)	22,787	22,641	22,071
Comprehensive income:
Net income	4,583	2,596	72,307
Other comprehensive income (net of tax):
Unrealized gain/(loss) on available for sale securities	96	-75	-30
Comprehensive income	$4,679	$2,521	$72,277

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net income	$4,583	$2,596	$72,307
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	541	458	453
Stock-based compensation	915	662	321
Gain on sale of patent assets	-2,127		-86,394
Amortization of premium (discount) on investments	-3	15	-18
(Gain)/loss on sale of investments	59	-23	-85
Deferred tax benefit (expense) on other comprehensive income	-66	81
Loss on disposal of property and equipment		28
Provision for doubtful accounts			4
Increase (decrease) from changes in assets and liabilities:
Accounts receivable	963	-1,125	85
Receivable from patent arrangement		1,121	-1,121
Inventories	1,599	-1,601	547
Prepaid expenses and other current assets	294	-167	-315
Deferred tax assets	173	563	-1,760
Accounts payable	-1,258	1,188	-71
Accrued expenses, compensation and professional	23	-310	9
Deferred revenue	560	-657	744
Net cash provided by (used in) operating activities	6,256	2,829	-15,294
Cash flows from investing activities:
Purchases of property and equipment	-135	-160	-116
Proceeds from sale of property and equipment		24
Purchases of investments		-2,008	-2,065
Sales of investments	1,432	1,117	855
Proceeds from sale of patent assets, net	2,127		86,394
Purchase of other assets		-338
Net cash provided by (used in) investing activities	3,424	-1,365	85,068
Cash flows from financing activities:
Proceeds from issuance of common stock	508	65	6,526
Payment of dividends	-39,905		-66,024
Excess tax benefits from stock-based compensation	1,247	128	14,395
Payments made for taxes of employees who surrendered shares related to unrestricted stock	-205	-71	-174
Repurchase of common stock
Net cash provided by (used in) financing activities	-38,355	122	-45,277
Increase/(decrease) in cash and cash equivalents	-28,675	1,586	24,497
Cash and cash equivalents, beginning of year	72,660	71,074	46,577
Cash and cash equivalents, end of year	43,985	72,660	71,074
Supplemental disclosure:
Cash paid for income taxes	$1,018	$542	$7,954

CONSOLIDATED_STATEMENTS_OF_STO

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	(Accumulated Deficit)	Total
In Thousands, except Share data, unless otherwise specified
Balance at Dec. 31, 2011	$206	$79,512	($20)	($25,123)	$54,575
Balance (in shares) at Dec. 31, 2011	20,623,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options	18	6,481			6,499
Exercise of common stock options (in shares)	1,764,000
Issuance of unrestricted stock	1	-1
Issuance of unrestricted stock (in shares)	151,000
Shares surrendered by employees to pay taxes related to unrestricted stock		-174			-174
Shares surrendered by employees to pay taxes related to unrestricted stock (in shares)	-33,000
Issuance of common stock under employee stock purchase plan		27			27
Issuance of common stock under employee stock purchase plan (in shares)	5,000
Stock-based compensation expense		321			321
Tax benefits from stock-based awards		14,395			14,395
Dividend payment				-66,024	-66,024
Accumulated other comprehensive loss:
Unrealized gain (loss) on securities			-30		-30
Net income				72,307	72,307
Balance at Dec. 31, 2012	225	100,561	-50	-18,840	81,896
Balance (in shares) at Dec. 31, 2012	22,510,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options		26			26
Exercise of common stock options (in shares)	6,000
Issuance of unrestricted stock	1	-1
Issuance of unrestricted stock (in shares)	65,000
Shares surrendered by employees to pay taxes related to unrestricted stock		-71			-71
Shares surrendered by employees to pay taxes related to unrestricted stock (in shares)	-14,000
Issuance of common stock under employee stock purchase plan		40			40
Issuance of common stock under employee stock purchase plan (in shares)	7,000
Stock-based compensation expense		662			662
Tax benefits from stock-based awards		128			128
Deferred tax asset write-off		-52			-52
Accumulated other comprehensive loss:
Unrealized gain (loss) on securities			-156		-156
Deferred tax benefit (expense) on unrealized gain (loss)			81		81
Net income				2,596	2,596
Balance at Dec. 31, 2013	226	101,293	-125	-16,244	85,150
Balance (in shares) at Dec. 31, 2013	22,574,000				22,574,251
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options	1	468			469
Exercise of common stock options (in shares)	118,000
Issuance of unrestricted stock	1	-1
Issuance of unrestricted stock (in shares)	141,000
Shares surrendered by employees to pay taxes related to unrestricted stock		-205			-205
Shares surrendered by employees to pay taxes related to unrestricted stock (in shares)	-32,000
Issuance of common stock under employee stock purchase plan		39			39
Issuance of common stock under employee stock purchase plan (in shares)	8,000
Stock-based compensation expense		915			915
Tax benefits from stock-based awards		1,247			1,247
Dividend payment				-39,905	-39,905
Accumulated other comprehensive loss:
Unrealized gain (loss) on securities			162		162
Deferred tax benefit (expense) on unrealized gain (loss)			-66		-66
Net income				4,583	4,583
Balance at Dec. 31, 2014	$228	$103,756	($29)	($51,566)	$52,389
Balance (in shares) at Dec. 31, 2014	22,809,000				22,808,761

NATURE_OF_BUSINESS

NATURE OF BUSINESS	12 Months Ended
	Dec. 31, 2014
Organization, Consolidation and Presentation Of Financial Statements [Abstract]
NATURE OF BUSINESS	1	NATURE OF BUSINESS
	We are a leading provider of software and services to the biometrics industry.  Our software products are used in government and commercial biometrics systems, which are capable of determining or verifying an individual’s identity. We also offer engineering services related to software customization, integration, and installation, as well as complete systems development. We sell our biometrics software products and services globally through systems integrators, OEMs, and directly to end user customers

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2.         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation - The consolidated financial statements include the accounts of Aware, Inc. and its subsidiary (“the Company”).  All significant intercompany transactions have been eliminated.

Use of Estimates – The preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period.  The most significant estimates included in the financial statements pertain to revenue recognition, reserves for doubtful accounts, useful lives of fixed assets, valuation allowance for deferred income tax assets, and accrued liabilities.  Actual results could differ from those estimates.

Fair Value Measurements - The Financial Accounting Standards Board (“FASB”) Codification defines fair value, and establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to the unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of the fair value hierarchy under the FASB Codification are: i) Level 1 – valuations that are based on quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date; ii) Level 2 – valuations that are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly; and iii) Level 3 – valuations that require inputs that are both significant to the fair value measurement and unobservable.

Cash and cash equivalents, which primarily include money market mutual funds, were $44.0 million and $72.7 million as of December 31, 2014 and December 31, 2013, respectively. We classified our cash equivalents of $34.3 million and $68.6 million as of December 31, 2014 and 2013, respectively, within Level 1 of the fair value hierarchy because they are valued using quoted market prices.

Our investments, which consist of high yield corporate debt securities, are also classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. Debt securities with maturities greater than one year are classified as long term assets. We categorize our investments as available-for-sale securities, and carry them at fair value in our financial statements.  We had $1.4 million and $2.8 million of available-for-sale investments as of December 31, 2014 and December 31, 2013, respectively.

As of December 31, 2014, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands):

Fair Value Measurement at December 31, 2014 Using:

Quoted Prices in

Significant Other

Significant Unobservable

Active Markets for

Observable Inputs

Inputs

Identical Assets

(Level 1)

(Level 2)

(Level 3)

Corporate debt securities

$

1,428

$

-

$

-

Money market funds (included in cash and cash equivalents)

34,339

Total

$

35,767

$

-

$

-

As of December 31, 2013, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands):

Fair Value Measurement at December 31, 2013 Using:

Quoted Prices in

Significant Unobservable

Active Markets for

Significant Other

Inputs

Identical Assets

Observable Inputs

(Level 1)

(Level 2)

(Level 3)

Corporate debt securities

$

2,754

$

-

$

-

Money market funds (included in cash and cash equivalents)

68,556

Total

$

71,310

$

-

$

-

Cash and Cash Equivalents – Cash and cash equivalents, which consist primarily of money market funds and demand deposits, are stated at fair value. All highly liquid investments purchased with an original maturity of three months or less are considered cash equivalents. Our cash balances exceed the Federal Deposit Insurance Corporation limits. The Company does not believe it is exposed to significant credit risk related to cash and cash equivalents.

Investments - At December 31, 2014 and 2013, we categorized all investment securities as available-for-sale, since we may liquidate these investments currently.  In calculating realized gains and losses, cost is determined using specific identification. Unrealized gains and losses on available-for-sale securities are excluded from earnings and reported in a separate component of stockholders’ equity called Accumulated Comprehensive Income.

Realized losses on investments were $59,000 in the year ended December 31, 2014. Realized gains on investments were $23,000 and $85,000 in the years ended December 31, 2013 and 2012, respectively.

Unrealized gains on investments were $162,000 in the year ended December 31, 2014. Unrealized losses on investments were $156,000, and $30,000 in the years ended December 31, 2013, and 2012.

The amortized cost of our corporate debt securities was $1.5 million at December 31, 2014. Corporate debt securities comprising investments mature in 2017 and 2018.

Allowance for Doubtful Accounts – Accounts are charged to the allowance for doubtful accounts as they are deemed uncollectible based on a periodic review of the accounts.

Inventories – Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out (“FIFO”) method.  We evaluate all inventories for net realizable value on a quarterly basis, and record provisions for excess and obsolete inventory when required.  There was no reserve for excess and obsolete inventory as of December 31, 2014.

Property and Equipment – Property and equipment is stated at cost.  Depreciation and amortization of property and equipment is provided using the straight-line method over the estimated useful lives of the assets. Upon retirement or sale, the costs of the assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain or loss on disposal is included in the determination of income or loss.  Expenditures for repairs and maintenance are charged to expense as incurred.

The estimated useful lives of assets used by us are:

Building

30 years

Building improvements

5 to 20 years

Furniture and fixtures

5 years

Computer, office & manufacturing equipment

3 years

Purchased software

3 years

Impairment of Long-Lived Assets – We review long-lived assets for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate.  Each impairment test is based on a comparison of the undiscounted cash flows estimated to be generated by those assets over their estimated economic life to the related carrying value of those assets to determine if the assets are impaired. If an impairment is indicated, the asset is written down to its estimated fair value.  The cash flow estimates used to identify the potential impairment reflect our best estimates using appropriate assumptions and projections at that time.  We believe that no significant impairment of our long-lived assets has occurred as of December 31, 2014 and 2013.

Revenue Recognition – We recognize revenue when there is persuasive evidence of an arrangement, the sales price is fixed or determinable, collection of the related receivable is reasonably assured, and delivery has occurred or services have been rendered.

Persuasive evidence of an arrangement: We use contracts signed by both the customer and us or written purchase orders issued by the customer as evidence of an arrangement.

Product delivery: We deem delivery to have occurred: (i) upon shipment when products are shipped FOB shipping point, or (ii) upon delivery at a customer’s location when products are shipped FOB destination, or (iii) when software is delivered electronically.  If customer acceptance provisions apply, revenue is not recognized until delivery has occurred and we have received such acceptance. If we are required to provide installation services, revenue is not recognized until installation is complete.

Fixed or determinable fee: We consider fees to be fixed or determinable if the fee is not subject to refund or adjustment and the payment terms are within normal established practices. If the fee is not fixed or determinable, we recognize the revenue as amounts become due and payable.

Collection is deemed probable: We conduct a credit review for significant transactions at the time of the arrangement to determine the credit-worthiness of the customer. Collection is deemed probable if we expect that the customer will pay amounts under the arrangement as payments become due.

We categorize revenue as software licenses, software maintenance, services, hardware, or royalties. In addition to the general revenue recognition policies described above, specific revenue recognition policies apply to each category of revenue.

Software licenses

Software licenses consist of revenue from the sale of software licenses for biometrics and imaging applications.  Our software licenses typically provide customers with the right to use our software in perpetuity.  We recognize revenue from software licenses upon delivery when licenses are sold in single element arrangements, because we have no post-delivery obligations, including contractual or implied Post Contract Support (“PCS”).

Software maintenance

Software maintenance consists of revenue from the sale of software maintenance contracts for biometrics and imaging software.  Software maintenance contracts entitle customers to receive software support and software updates, if and when they become available, during the term of the maintenance contract. We recognize software maintenance revenue ratably over the related contract period.

Services

Service revenue consists of fees from biometrics customers for software engineering services we provide to them. We recognize services revenue as services are delivered when services are sold in single element arrangements.

Hardware

Hardware revenue consists of sales of biometrics equipment to a single U.S. government customer.  We recognize hardware revenue upon delivery and acceptance of the equipment by the customer.

Royalties

Royalties consist primarily of royalty payments we receive under DSL silicon contracts with two customers that incorporate our silicon intellectual property (“IP”) in their DSL chipsets.  We sold the assets of our DSL IP business in 2009, but we continue to receive royalty payments from these customers.  Royalties are reported in continuing operations in accordance with ASC 205, Reporting Discontinued Operations, because we have continuing ongoing cash flows from this business.

Since we cannot reasonably estimate royalty revenue, such revenue is recognized in the quarter in which a final report is received from a customer. Royalty reports are typically received in the quarter immediately following the quarter in which sales of royalty-bearing products occur.

Multiple element arrangements with software and software related elements

In addition to selling software licenses, software maintenance and software services in single element arrangements, we also sell these three products as part of multiple element arrangements.  We apply the provisions of ASC 985-605, Software Revenue Recognition, to these arrangements because all the elements are software or software related.  The various combinations of multiple element arrangements and our revenue recognition for each are described as follows:

●

Software licenses and software maintenance. When software licenses and software maintenance contracts are sold together, we recognize software license revenue upon delivery, provided we have vendor specific objective evidence (“VSOE”) for the fair value of the maintenance contract fee, and we recognize the fair value of maintenance contract revenue ratably over the related contract period. Under ASC 985-605, the residual method is the appropriate manner in which to allocate arrangement consideration to the license when VSOE exists for all undelivered elements (e.g., PCS), but not for the delivered element (e.g., the license).

●

Software licenses and services. When software licenses and software engineering services are sold together, the total fee is generally recognized by applying contract accounting. We have adopted the percentage-of-completion method of contract accounting, and we generally use an input method (i.e., labor hours) to determine our completion percentage. The software license portion of the arrangement is classified as software license revenue and the engineering services portion is classified as services revenue in our consolidated statements of income and comprehensive income.

●

Software licenses, software maintenance and services. When we sell software licenses, software maintenance and software services together, revenue is recognized as follows: i) software maintenance revenue is separated from the other two elements and is recognized ratably over the related software maintenance contract period; provided we have VSOE for the fair value of the maintenance element; and ii) the total fee from the software license and engineering service elements is recognized by applying the contract accounting method described in the previous paragraph.

Multiple element arrangement with hardware and software elements

We also have a multiple element arrangement with one customer that involves the delivery of hardware, software maintenance, and software services.  We determined that these elements qualified as separate units of accounting under ASC 605, Revenue Recognition, because they have value to the customer on a standalone basis.  We recognize revenue from this arrangement as follows: i) hardware revenue is recognized upon delivery and acceptance of the equipment by the customer; ii) maintenance revenue is recognized ratably over the related contract period; and iii) service revenue is recognized as services are delivered.

Income Taxes – We compute deferred income taxes based on the differences between the financial statement and tax basis of assets and liabilities using enacted rates in effect in the years in which the differences are expected to reverse.  We establish a valuation allowance to offset temporary deductible differences, net operating loss carryforwards and tax credits when it is more likely than not that the deferred tax assets will not be realized.

We recognize the tax benefit from an uncertain tax position only if it is more-likely-than-not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the tax position. The evaluation of an uncertain tax position is based on factors that include, but are not limited to, changes in the tax law, the measurement of tax positions taken or expected to be taken in tax returns, the effective settlement of matters subject to audit, and changes in facts or circumstances related to a tax position.  Any changes to these estimates, based on the actual results obtained and/or a change in assumptions, could impact our tax provision in future periods.  Interest and penalty charges, if any, related to unrecognized tax benefits would be classified as a provision for income tax in the statement of income.

Capitalization of Software Costs – We capitalize certain internally developed software development costs after technological feasibility of the product has been established.  No software costs were capitalized for the years ended December 31, 2014, 2013 and 2012, because such costs incurred subsequent to the establishment of technological feasibility, but prior to commercial availability, were immaterial.

Research and Development Costs – Costs incurred in the research and development of our products are expensed as incurred.

Concentration of Credit Risk – At December 31, 2014 and 2013, we had cash and cash equivalents, in excess of federally insured deposit limits of approximately $43.7 million and $72.4 million, respectively.

Concentration of credit risk with respect to net accounts receivable consisted of amounts owed by the following customers that comprised more than 10% of net accounts receivable at December 31:

2014

2013

Customer A

18

%

60

%

Customer B

15

%

-

%

Customer C

11

%

-

%

Concentration of credit risk with respect to our investment portfolio consisted of $0.5 million, $0.5 million, and $0.4 million with three issuers of corporate debt securities, respectively, at December 31, 2014, and $0.8 million, $0.5 million, $0.5 million, $0.5 million, and $0.4 million with five issuers of corporate debt securities, respectively, at December 31, 2013.

Stock-Based Compensation – We grant stock and stock options to our employees and directors.  We measure stock-based compensation cost at the grant date based on the fair value of the award and recognize stock-based compensation expense on a straight-line basis over the requisite service period of the award.

For stock awards, we determine the fair value of the award by using the fair market value of our stock on the date of grant; provided the number of shares in the grant is fixed on the grant date.

For stock options, we use the Black-Scholes option valuation model to estimate the fair value of the award. This valuation model takes into account the exercise price of the award, as well as a variety of significant assumptions.  The assumptions used to estimate the fair value of stock options include the expected term, the expected volatility of our stock over the expected term, the risk-free interest rate over the expected term, and our expected annual dividend yield.

Computation of Earnings per Share – Basic earnings per share is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding.  Diluted earnings per share is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding plus additional common shares that would have been outstanding if dilutive potential common shares had been issued.  For the purposes of this calculation, stock options are considered common stock equivalents in periods in which they have a dilutive effect.  Stock options that are antidilutive are excluded from the calculation.

Fair Value of Financial Instruments – The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value because of their short-term nature. The carrying amount of investments is based on the fair value of the individual securities in our investment portfolio.

Advertising Costs – Advertising costs are expensed as incurred and were not material for 2014, 2013, and 2012.

Recent Accounting Pronouncements – In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). The ASU is the result of a joint project by the FASB and the International Accounting Standards Board (“IASB”) to clarify the principles for recognizing revenue and to develop a common revenue standard for GAAP and International Financial Reporting Standards (“IFRS”) that would: remove inconsistencies and weaknesses, provide a more robust framework for addressing revenue issues, improve comparability of revenue recognition practices across entities, jurisdictions, industries, and capital markets, improve disclosure requirements and resulting financial statements, and simplify the presentation of financial statements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU is effective for annual reporting periods beginning after December 15, 2016.  Early adoption is not permitted. We are currently evaluating the effect that the updated standard will have on our consolidated financial statements and related disclosures.

With the exception of the new revenue standard discussed above, there have been no other recently issued accounting pronouncements that are of significance or potential significance to us that we have not adopted as of December 31, 2014.

Reclassifications - Certain prior period amounts have been reclassified to be consistent with the current period presentation.

Segments – We organize ourselves into a single segment reporting to the chief operating decision makers. We have sales outside of the United States, which are described in Note 10.  All long-lived assets are maintained in the United States.

PATENT_RELATED_INCOME

PATENT RELATED INCOME	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
PATENT RELATED INCOME	3	PATENT RELATED INCOME
	Patent related income in the years ended December 31, 2014, 2013 and 2012 was derived from either gains on the sale of patent assets or income from a patent arrangement, or both. Income from these sources was included in income from continuing operations pursuant to ASC 360-10, Impairment or Disposal of Long-Lived Assets, and Rule 5-03 of Regulation S-X.
	The composition of patent related income in 2014, 2013, and 2012 was as follows:
	Year ended December 31, 2014. We had a $2.1 million gain on the sale of patent assets and no income from our patent arrangement in 2014. The gain on the sale of patent assets is described below:
	We sold a portion of our patent portfolio pertaining to DSL diagnostic technology to an unrelated third party for $2.6 million. The proceeds from the sale were reduced by $0.5 million of transaction costs, which consisted primarily of fees from the law firm that assisted us in the sale.  We recorded a gain of $2.1 million on the sale.
	The DSL diagnostic technology in the patents we sold in 2014 was related to our DSL Service Assurance business that we shut down in 2012 and 2013 and reported in discontinued operations in those periods. We do not consider our patent related activities to be a component of the operating business from which the underlying technology was derived, but rather as a component of corporate general and administrative expenses.  Accordingly the gain on the sale of these patents was reported in income from continuing operations.
	Year ended December 31, 2013. We had $0.8 million of income from a patent arrangement and no gains on the sale of patent assets in 2013.  Income from the patent arrangement is described below:
	We entered into an arrangement with an unaffiliated third party in 2010 under which we assigned certain patents in return for royalties on proceeds from patent monetization efforts by the third party.  Such third party has engaged in various patent monetization activities, including enforcement, litigation and licensing. The party reported and we recorded $0.8 million of income from this arrangement in the year ended December 31, 2013.
	We continue to have a contractual relationship with this third party. However, we are unable to predict how much more income we might receive from this arrangement, if any, because:
		●	The claims in one of the patents we assigned were rejected by the United States Patent Office (“USPTO”) in May 2013. The USPTO’s Patent Trial & Appeal Board (“PTAB”) affirmed the USPTO decision in June 2014.  The PTAB decision was appealed to the Federal Circuit.  In December 2014, the Federal Circuit remanded the appeal back to the PTAB for further consideration.
		●	Notwithstanding the outcome at the PTAB, we do not know whether any patent monetization efforts by the third party will be successful.
	Year ended December 31, 2012. We had total patent related income of $87.5 million in 2012, which consisted of $86.4 million of gains on the sale of patent assets and $1.1 million of income from our patent arrangement. Patent related income in 2012 is described below:
	Gains on the sale of patent assets. Total gains on the sale of patent assets in 2012 were $86.4 million, which consisted of gains from two separate sales.  Gains from both sales were recorded in income from continuing operations as none of these patents were related to any discontinued operations, including our discontinued DSL Service Assurance business.  The two sales are described below:
		●	We sold a portion of our patent portfolio pertaining to wireless technology to an unaffiliated third party for $75.0 million. The proceeds from the sale were reduced by $3.8 million of transaction costs, which consisted primarily of fees from the law firm that assisted us in the sale.  We recorded a gain of $71.2 million on the sale.
		●	We sold a portion of our patent portfolio pertaining to DSL semiconductor intellectual property technology for $16.0 million. The proceeds from the sale were reduced by $0.8 million of transaction costs, which also consisted primarily of fees from the law firm that assisted us in the sale.  We recorded a gain of $15.2 million on the sale.
	Income from patent arrangement.  The third party to whom we assigned patents reported and we recorded $1.1 million of income from this arrangement in the year ended December 31, 2012.

DISCONTINUED_OPERATIONS

DISCONTINUED OPERATIONS	12 Months Ended
	Dec. 31, 2014
Discontinued Operations and Disposal Groups [Abstract]
DISCONTINUED OPERATIONS	4	DISCONTINUED OPERATIONS
	Our board of directors approved the shutdown of our DSL service assurance hardware and software product lines in 2012 and 2013, respectively. Both product lines were previously components of our DSL Service Assurance Segment. Results from the DSL Service Assurance Segment have been reported as discontinued operations because we no longer have any significant continuing involvement with, or cash flows from, this segment.
	Loss from the discontinued DSL Service Assurance Segment was (in thousands):
			Years ended December 31,
			2014		2013			2012
	Revenue		$	-	$	3,216		$	5,431
	Expenses			-		5,120			5,558
	Loss before income taxes			-		(1,904	)		(127	)
	Income tax benefit			-		(748	)		(51	)
	Loss from discontinued operations		$	-	($	1,156	)	($	76	)
	The consolidated statements of income and comprehensive income for the year ended December 31, 2012 was reclassified to reflect the effect of discontinued operations as set forth above.
	We incurred one-time costs related to the shutdown of the DSL service assurance hardware and software product lines.  Shutdown costs for each product line were:
	DSL service assurance hardware product line.  In 2012, we incurred one-time shutdown costs related to the hardware product line of approximately $0.3 million, the majority of which were severance and employee-related costs.  All such costs were incurred, paid, and included in loss from discontinued operations for the year ended December 31, 2012.
	DSL service assurance software product line.  In 2013, we incurred one-time shutdown costs related to the software product line of approximately $2.9 million. Such costs comprise: i) $3.7 million of payments to customers to terminate contracts, which were offset by $1.2 million of deferred revenue obligations that were relieved as a result of such contract terminations; ii) $0.3 million of severance and employee-related costs; and iii) $48,000 of asset write-offs.  All such costs were incurred and included in loss from discontinued operations for the year ended December 31, 2013. All DSL service assurance software product line exit costs were paid in 2013, with the exception of $0.1 million of severance costs, which were paid in early January 2014.
	There were no assets or liabilities remaining on the balance sheet as of December 31, 2014 related to the DSL Service Assurance Segment.

INVENTORIES

INVENTORIES	12 Months Ended
	Dec. 31, 2014
Inventory Disclosure [Abstract]
INVENTORIES	5	INVENTORIES
	Inventories consisted of the following at December 31 (in thousands):
			2014		2013
	Raw materials		$	2	$	1,584
	Finished goods			-		17
	Total		$	2	$	1,601

PROPERTY_AND_EQUIPMENT

PROPERTY AND EQUIPMENT	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	6	PROPERTY AND EQUIPMENT
	Property and equipment consisted of the following at December 31 (in thousands):
			2014			2013
	Land		$	1,056		$	1,056
	Building and improvements			9,060			9,060
	Computer equipment			614			557
	Purchased software			78			88
	Furniture and fixtures			778			778
	Office equipment			191			191
	Total			11,777			11,730
	Less accumulated depreciation and amortization			(6,488	)		(6,148	)
	Property and equipment, net		$	5,289		$	5,582
	Depreciation expense was $0.4 million, $0.5 million, and $0.4 million for the years ended December 31, 2014, 2013, and 2012, respectively.  In 2014, 2013 and 2012, we identified $0.1 million, $0.3 million, and $1.0 million of assets no longer in use and retired the assets and related accumulated depreciation.

INCOME_TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
INCOME TAXES	7.        INCOME TAXES
	We made provisions for income taxes related to continuing operations in the years ended December 31, 2014, 2013 and 2012 of $2.7 million, $1.9 million and $20.5 million, respectively. The components of the provision for income taxes are as follows (in thousands):
		Year ended December 31,
		2014			2013			2012
	Current:
	Federal	$	1,976		$	1,000		$	20,654
	State		589			273			1,594
			2,565			1,273			22,248
	Deferred:
	Federal		93			471			(1,354	)
	State		14			173			(407	)
			107			644			(1,761	)
	Total provision for income taxes	$	2,672		$	1,917		$	20,487
	A reconciliation of the U.S. federal statutory rate to the effective tax rate is as follows:
		Year ended December 31,
		2014			2013			2012
	Federal statutory rate		34	%		34	%		35	%
	State rate, net of federal benefit		5			5			5
	Tax credits		(1	)		(2	)		-
	Permanent adjustments		(1	)		(1	)		-
	Change in valuation allowance		-			-			(18	)
	Prior year adjustment		-			(2	)		-
	Effective tax rate		37	%		34	%		22	%
	Total income tax expense for the year ended December 31, 2014 was $2.7 million, all of which was included in continuing operations. Income tax expense for 2014 was based on the U.S. statutory rate of 34%, increased by state income taxes, and reduced by Federal research tax credits and permanent adjustments.
	Total income tax expense for the year ended December 31, 2013 was $1.2 million, including $1.9 million of tax expense that was recorded in continuing operations less a tax benefit of $0.7 million that was recorded in discontinued operations. Income tax expense for 2013 was based on the U.S. statutory rate of 34%, increased by state income taxes, and reduced by Federal research tax credits and permanent adjustments.  Tax expense in 2013 also reflects two items related to 2012, including: i) a tax benefit of $0.1 million related to the 2012 research tax credit. This credit was extended retroactively back to January 1, 2012, by the American Taxpayer Relief Act of 2012, which was enacted on January 2, 2013; and ii) a tax benefit of $0.1 million related to a reduction in the estimate of the 2012 tax expense recorded in our 2012 financial statements.
	Total income tax expense for the year ended December 31, 2012 was $20.4 million, including $20.5 million of tax expense that was recorded in continuing operations less a tax benefit of $51,000 that was recorded in discontinued operations. Our actual tax liability for 2012 was $7.8 million as taxes that were currently payable were reduced by a $14.4 million equity adjustment. This equity adjustment is described more fully below.
	In 2012, we used a significant portion of our available deferred tax assets to reduce income taxes on pre-tax income. A substantial portion of the deferred tax assets we utilized comprised cumulative deductions for stock options in excess of book expense. Under income tax accounting rules, the portion of tax benefits attributable to such deductions must be recorded as an adjustment to equity versus a reduction of income tax expense. In the year ended December 31, 2012, the tax benefits from such stock-based awards were $14.4 million, which we recorded as an equity adjustment to additional paid-in capital.
	Income tax expense in 2012 was also reduced by a $1.8 million reversal of the valuation allowance on our remaining deferred tax assets at December 31, 2012. We reversed the valuation allowance because based on all the available evidence, we believed that it is more likely than not that our deferred tax assets will be realizable.  In reaching this determination, we evaluated: i) our most recent years operating results; ii) our future financial plans; and iii) the nature of the components comprising deferred tax assets at December 31, 2012.
	As of December 31, 2014 and 2013, we had deferred tax assets for which we had recorded no valuation allowance.  The principal components of deferred tax assets were as follows at December 31 (in thousands):
		2014			2013
	Depreciation	$	374		$	418
	Stock compensation		303			199
	Capitalized research and development costs		96			364
	Other		199			164
	Total		972			1,145
	Less valuation allowance		(-	)		(-	)
	Deferred tax assets, net	$	972		$	1,145
	We will continue to assess the level of valuation allowance required in future periods. Should evidence regarding the realizability of tax assets change at a future point in time, the valuation allowance will be adjusted accordingly.
	As a result of significant taxable income in 2012 and the utilization of research and development credits thereon, we conducted a review to determine whether any of our prior year research and development tax credits represented an uncertain tax position.  Based on that review, we determined that $1.9 million of federal credits and $1.0 million of state credits could not be supported and therefore, those credits were written off.  In addition to the write-off, we also determined that $1.9 million of federal credits and $1.0 million of state credits represented an uncertain tax position for which we established a valuation allowance.  A rollforward of the uncertain tax position related to our research and development tax credits is as follows (in thousands):
	Uncertain tax positions at December 31, 2011	$	-
	Increase due to positions taken in prior periods		2,945
	Uncertain tax positions at December 31, 2012	$	2,945
	Increase due to positions taken in prior periods		-
	Uncertain tax positions at December 31, 2013	$	2,945
	Increase due to positions taken in prior periods		-
	Uncertain tax positions at December 31, 2014	$	2,945
	Uncertain tax positions of $2.6 million will impact our tax rate if realized.  The difference between this amount and the total uncertain tax positions in the table above is the federal tax effect on state tax credits.
	In addition to deferred tax assets carried on our balance sheet, we also had net federal and state research and development credit carryforwards available at December 31, 2014 of $4.0 million and $0.3 million.  These credits were not recorded as tax assets as they relate to excess stock compensation deductions that may not be recorded as tax assets under generally accepted accounting principles until the amounts have been utilized to reduce our tax liability. To the extent that these assets are used to reduce future taxes, the benefit will be recorded as a reduction to additional paid-in capital. In 2014 and 2013, we recorded tax benefits of $1.2 million and $0.1 million to equity related to the use of these tax credits to reduce our tax liability.
	Our policy is to recognize interest and penalties related to uncertain tax positions in income tax expense.  As of December 31, 2014, we had no accrued interest or penalties related to uncertain tax positions.
	The tax years from 1999 through 2014 are subject to examination by the IRS and state tax authorities. In the third quarter of 2014, the Internal Revenue Service commenced an examination of our tax return for the year ended December 31, 2012.

EQUITY_AND_STOCK_COMPENSATION_

EQUITY AND STOCK COMPENSATION PLANS	12 Months Ended
	Dec. 31, 2014
Shareholders Equity and Share Based Payments [Abstract]
EQUITY AND STOCK COMPENSATION PLANS	8.         EQUITY AND STOCK COMPENSATION PLANS
	Fixed Stock Option Plans – We have two fixed option plans.  Under our 1996 Stock Option Plan (“1996 Plan”), we were authorized to grant incentive stock options and nonqualified stock options to our employees and directors for up to 6,100,000 shares of common stock. There were no shares available for grant under the 1996 Plan as of December 31, 2014.  Under our 2001 Nonqualified Stock Plan (“2001 Plan”), we are authorized to grant nonqualified stock options, stock appreciation rights and stock awards to our employees and directors for up to 8,000,000 shares of common stock.  As of December 31, 2014, there were 5,062,381 shares available for grant under the 2001 Plan.
	Under both plans, options are granted at exercise prices as determined by the Board of Directors and have terms ranging from four to a maximum of ten years. Our options generally vest over three to five years.
	The following table presents stock-based employee compensation expenses included in our consolidated statements of income and comprehensive income (in thousands):
		Years ended December 31,
		2014			2013		2012
	Cost of services	$	44		$	34	$	16
	Research and development		106			81		51
	Selling and marketing		17			14		126
	General and administrative		748			533		83
	Loss from discontinued operations		-			-		45
	Stock-based compensation expense	$	915		$	662	$	321
	Stock-based compensation expenses in the preceding table include expenses associated with grants of: i) stock options; and iii) unrestricted shares of our common stock.  The method used to determine stock-based compensation expense for each type of equity grant is described in the following paragraphs.
	Stock Option Grants. For the years ended December 31, 2014, 2013, and 2012, we granted stock options for 0, 0, and 50,000 shares, respectively. We estimate the fair value of stock options using the Black-Scholes valuation model.
	The Black-Scholes valuation model takes into account the exercise price of the award, as well as a variety of significant assumptions. The assumptions used to estimate the fair value of stock options include the expected term, the expected volatility of our stock over the expected term, the risk-free interest rate over the expected term, and our expected annual dividend yield. We believe that the valuation technique and the approach utilized to develop the underlying assumptions are appropriate in calculating the fair values of stock options granted in the year ended December 31, 2012. Estimates of fair value are not intended to predict actual future events or the value ultimately realized by persons who receive equity awards.
	We did not grant any stock options in 2014 and 2013.  Specific assumptions used to determine the fair value of options granted during the year ended December 31, 2012, using the Black-Scholes valuation model were:
		Year Ended
		31-Dec-12
	Expected term (1)	5 years
	Expected volatility factor (2)		58-63	%
	Risk-free interest rate (3)		0.92	%
	Expected annual dividend yield		n/a
	(1) The expected term for each grant was determined based on the contractual term of the option.
	(2) The expected volatility for each grant is estimated based on an average of historical volatility over a period of time which we believe to be representative of our future volatility.
	(3) The risk-free interest rate for each grant is based on the U.S. Treasury yield curve in effect at the time of grant for a period equal to the expected term of the stock option.
	We do not estimate our forfeiture rates as the actual forfeiture rate is known at the end of each reporting period due to the timing of our stock option vesting.
	Unrestricted Stock Grants.  Our 2001 Plan permits us to grant shares of unrestricted stock to our directors, officers and employees.  Stock-based compensation expense for stock grants is determined based on the fair market value of our stock on the date of grant; provided the number of shares in the grant is fixed on the grant date.
	We granted 152,000, 130,000, and 0 shares of unrestricted stock during the years ended December 31, 2014, 2013, and 2012, respectively. The accounting treatment of those awards is described below:
	Year ended December 31, 2014. In March 2014, we granted 152,000 shares of unrestricted stock to directors, officers and employees. The shares were issued in two equal installments shortly after June 30, 2014 and December 31, 2014. We expensed $876,000 of stock-based compensation expense related to this grant in the year ended December 31, 2014. There was no unamortized stock-based compensation charge associated with this stock grant as of December 31, 2014.
	We issued shares of common stock related to the March 2014 grant as follows: i) 58,769 net shares of common stock were issued in early July 2014 after employees surrendered 17,231 shares for which we paid $113,000 of withholding taxes on their behalf; and ii) 56,804 shares of common stock were issued in early January 2015 after employees surrendered 19,196 shares for which we paid $87,000 of withholding taxes on their behalf.
	Year ended December 31, 2013. In April 2013, we granted 130,000 shares of unrestricted stock to directors, officers and employees. The shares were issued in two equal installments shortly after June 30, 2013 and December 31, 2013. We expensed $623,000 of stock-based compensation expense related to this grant in the year ended December 31, 2013. There was no unamortized stock-based compensation charge associated with this stock grant as of December 31, 2013.
	We issued shares of common stock related to the April 2013 grant as follows: i) 51,374 net shares of common stock were issued in early July 2013 after employees surrendered 13,626 shares for which we paid $71,000 of withholding taxes on their behalf; and ii) 49,936 net shares of common stock were issued in early January 2014 after employees surrendered 15,064 shares for which we paid $92,000 of withholding taxes on their behalf.
	Year ended December 31, 2012. No shares of unrestricted stock were granted in 2012, however we granted shares of unrestricted common stock in 2010 that affected results for the year ended December 31, 2012. Activity in 2012 related to the 2010 stock grant was: i) 2012 stock-based compensation expense included $189,000 related to the 2010 grant; and ii) we issued 118,113 net shares of common stock after employees surrendered 33,441 shares for which we paid $174,000 of withholding taxes on their behalf.
	A summary of stock option transactions for our two fixed stock option plans for the years ended December 31, 2014, 2013, and 2012 are presented below:
		2014					2013					2012
					Weighted					Weighted					Weighted
					Average					Average					Average
		Shares			Exercise		Shares			Exercise		Shares			Exercise
					Price					Price					Price
	Outstanding at beginning of year		1,004,989		$	5.68		1,063,025		$	5.63		2,835,952		$	4.42
	Granted		-			-		-			-		50,000			4.6
	Exercised		(117,783	)		3.98		(6,163	)		4.27		(1,779,616	)		3.71
	Forfeited or cancelled		(781,004	)		6.07		(51,873	)		4.83		(43,311	)		4.33
	Outstanding at end of year		106,202		$	4.71		1,004,989		$	5.68		1,063,025		$	5.63
	Exercisable at year end		104,117		$	4.69		986,237		$	5.7		1,027,525		$	5.66
	The number of option shares vested and expected to vest at December 31, 2014 was 106,202 and those options had a weighted average exercise price of $4.71.
	No stock options were granted in the years ended December 31, 2014 and 2013. All options granted during the year ended December 31, 2012 had exercise prices equal to the fair market value of our common stock on the date of grant, and the weighted average grant date fair values of options granted were $2.38.
	At December 31, 2014, the weighted average remaining contractual term for total options outstanding and total options exercisable was approximately 2.5 years for each.
	At December 31, 2014, the aggregate intrinsic value of options outstanding and options exercisable was zero for each. The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option.  The aggregate intrinsic value of options exercised during the year ended December 31, 2014 was approximately $301,000.
	The following table summarizes the stock options outstanding at December 31, 2014:
		Options Outstanding								Options Exercisable
	Exercise Price	Number			Weighted					Number		Weighted
	Range				Average		Weighted Average					Average
					Exercise		Remaining					Exercise
					Price		Contractual					Price
							Term (in years)
	$2 to $3		18,000		$	2.52		4.39			18,000	$	2.52
	$3 to $4		14,168			3.57		2.82			14,168		3.57
	$4 to $5		33,200			4.64		2.93			33,200		4.64
	$6 to $7		40,834			6.14		1.27			38,749		6.14
			106,202		$	4.71		2.52			104,117	$	4.69
	At December 31, 2014, unrecognized compensation expense related to non-vested stock options was approximately $7,000, which is expected to be recognized over a weighted average period of 0.25 years.
	We issue common stock from previously authorized but unissued shares to satisfy option exercises and purchases under our Employee Stock Purchase Plan.
	Employee Stock Purchase Plan - In June 1996, we adopted an Employee Stock Purchase Plan (the “ESPP Plan”) under which eligible employees could purchase common stock at a price equal to 85% of the lower of the fair market value of the common stock at the beginning or end of each six-month offering period.  On November 29, 2005 we amended the ESPP Plan to provide that eligible employees may purchase common stock at a price equal to 95% of the fair market value of the common stock as of the end of each six-month offering period.  There is no stock-based compensation expense related to our Employee Stock Purchase Plan because it is not considered a compensatory plan. The plan does not have a look-back feature, and has a minimal discount of 5% of the fair market value of the common stock as of the end of each six-month offering period.  Participation in the ESPP Plan is limited to 6% of an employee’s compensation, may be terminated at any time by the employee and automatically ends on termination of employment.  A total of 350,000 shares of common stock have been reserved for issuance.  As of December 31, 2014 there were 100,937 shares available for future issuance under the ESPP Plan.  We issued 8,022, 7,196, and 4,661 common shares under the ESPP Plan in 2014, 2013, and 2012, respectively.
Dividends – We paid dividends in the years ended December 31, 2014 and 2012 as follows:
Year ended December 31, 2014.  On June 26, 2014, our board of directors declared a special cash dividend of $1.75 per share. The dividend was paid on July 24, 2014 to shareholders of record as of July 10, 2014.  The total dividend payment was $39.9 million.
Year ended December 31, 2012.  In April 2012, our board of directors declared a special cash dividend of $1.15 per share. The dividend was paid on May 25, 2012 to shareholders of record as of May 11, 2012.  The total amount of the dividend paid was $25.5 million.  In November 2012, our board of directors declared a second special cash dividend of $1.80 per share. The dividend was paid on December 17, 2012 to shareholders of record as of December 3, 2012.  The total amount of the dividend paid was $40.5 million.

COMMITMENTS_AND_CONTINGENT_LIA

COMMITMENTS AND CONTINGENT LIABILITIES	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENT LIABILITIES	9	COMMITMENTS AND CONTINGENT LIABILITIES
	Lease Commitments – We own our principal office and research facility in Bedford, Massachusetts, which we have occupied since November 1997.  We also conducted a portion of our activities in a leased facility in California in 2012 that we terminated in that year.  Rental expense for the California facility was $0, $0, and $25,000 in 2014, 2013 and 2012, respectively.
	Litigation - There are no material pending legal proceedings to which we are a party or to which any of our properties are subject which, either individually or in the aggregate, are expected to have a material adverse effect on our business, financial position or results of operations.
	Guarantees and Indemnification Obligations – We enter into agreements in the ordinary course of business that require us: i) to perform under the terms of the contracts, ii) to protect the confidentiality of our customers’ intellectual property, and iii) to indemnify customers, including indemnification against third party claims alleging infringement of intellectual property rights.  We also have agreements with each of our directors and executive officers to indemnify such directors or executive officers, to the extent legally permissible, against all liabilities reasonably incurred in connection with any action in which such individual may be involved by reason of such individual being or having been a director or officer of the Company.
	Given the nature of the above obligations and agreements, we are unable to make a reasonable estimate of the maximum potential amount that we could be required to pay.  Historically, we have not made any significant payments on the above guarantees and indemnifications and no amount has been accrued in the accompanying consolidated financial statements with respect to these guarantees and indemnifications.

BUSINESS_SEGMENTS_AND_MAJOR_CU

BUSINESS SEGMENTS AND MAJOR CUSTOMERS	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
BUSINESS SEGMENTS AND MAJOR CUSTOMERS	10.       BUSINESS SEGMENTS AND MAJOR CUSTOMERS
	We organize ourselves into a single segment that reports to the chief operating decision makers.
	We conduct our operations in the United States and sell our products and services to domestic and international customers.  Revenues were generated from the following geographic regions (in thousands):
		Year ended December 31,
		2014			2013			2012
	United States	$	18,168		$	13,909		$	12,158
	Rest of world		5,552			5,448			5,146
		$	23,720		$	19,357		$	17,304
	There were no single foreign countries from which we derived 10% or more of total revenue in the years ended December 31, 2014, 2013, and 2012.
	Revenue by product group was (in thousands):
		Year ended December 31,
		2014			2013			2012
	Biometrics	$	21,436		$	17,085		$	13,493
	Imaging		1,558			1,352			1,641
	DSL royalties		726			920			2,170
		$	23,720		$	19,357		$	17,304
	The portion of total revenue that was derived from major customers was as follows:
		Year ended December 31,
		2014			2013			2012
	Customer A		24	%		21	%		5	%
	Customer B		10	%		3	%		-	%

EMPLOYEE_BENEFIT_PLAN

EMPLOYEE BENEFIT PLAN	12 Months Ended
	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
EMPLOYEE BENEFIT PLAN	11	EMPLOYEE BENEFIT PLAN
	In 1994, we established a qualified 401(k) Retirement Plan (the “Plan”) under which employees are allowed to contribute certain percentages of their pay, up to the maximum allowed under Section 401(k) of the Internal Revenue Code.  Our contributions to the Plan are at the discretion of the Board of Directors.  Our contributions were approximately $198,000, $189,000, and $233,000 in 2014, 2013 and 2012, respectively.

NET_INCOME_PER_SHARE

NET INCOME PER SHARE	12 Months Ended
	Dec. 31, 2014
Earnings Per Share [Abstract]
NET INCOME PER SHARE	12	NET INCOME PER SHARE
	Net income per share is calculated as follows (in thousands, except per share data):
			Year ended December 31,
			2014		2013			2012
	Net income:
	Income from continuing operations		$	4,583	$	3,752		$	72,383
	Loss from discontinued operations			-		(1,156	)		(76	)
	Net income		$	4,583	$	2,596		$	72,307
	Shares outstanding:
	Weighted-average common shares outstanding			22,703		22,543			21,814
	Additional dilutive common stock equivalents			84		98			257
	Diluted shares outstanding			22,787		22,641			22,071
	Basic net income per share:
	Basic net income per share from continuing operations		$	0.2	$	0.17		$	3.32
	Basic net loss per share from discontinued operations			-		(0.05	)		(0.00	)
	Basic net income per share		$	0.2	$	0.12		$	3.32
	Diluted net income per share:
	Diluted net income per share from continuing operations		$	0.2	$	0.16		$	3.28
	Diluted net loss per share from discontinued operations			-		(0.05	)		(0.00	)
	Diluted net income per share		$	0.2	$	0.11		$	3.28
	For the years ended December 31, 2014, 2013 and 2012, options to purchase 40,834, 823,338, and 821,838 shares of common stock at weighted average exercise prices of $6.14, $6.07, and $6.07 per share, respectively, were outstanding, but were not included in the computation of diluted EPS because the options’ exercise prices were greater than the average market price of the common shares and thus would be anti-dilutive.

ACCUMULATED_OTHER_COMPREHENSIV

ACCUMULATED OTHER COMPREHENSIVE LOSS	12 Months Ended
	Dec. 31, 2014
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Income Loss [Text Block]	13.       ACCUMULATED OTHER COMPREHENSIVE LOSS
	The components of accumulated other comprehensive loss and activity were as follows (in thousands):
			December 31,			Increase/			Reclassification			December 31,
			2013			Decrease			Adjustments			2014
	Unrealized losses on available for sale securities		($	206	)	$	60		$	59		($	87	)
	Unrealized gains on available for sale securities			-			43			-			43
	Net unrealized gains (losses) on available for sale securities			(206	)		103			59	(a)		(44	)
	Income tax benefit (expense) on other comprehensive loss			81			(46	)		(20	)		15
	Total accumulated other comprehensive loss, net of taxes		($	125	)	$	57		$	39		($	29	)
	(a)	– Classified in other expense.

QUARTERLY_RESULTS_OF_OPERATION

QUARTERLY RESULTS OF OPERATIONS UNAUDITED	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
QUARTERLY RESULTS OF OPERATIONS - UNAUDITED
	14.      QUARTERLY RESULTS OF OPERATIONS – UNAUDITED
	The following table is a summary of certain items in the consolidated statements of income and comprehensive income for each of our quarters in the two-year period ended December 31, 2014 (in thousands, except per share data).
		2014 Quarters Ended
		31-Mar			30-Jun			30-Sep			31-Dec
	Revenue	$	6,617		$	6,767		$	6,027		$	4,309
	Operating income		1,311			1,382			4,155			243
	Income from continuing operations		880			865			2,599			239
	Income from discontinued operations		-			-			-			-
	Net income		880			865			2,599			239
	Net income per share – basic	$	0.04		$	0.04		$	0.11		$	0.01
	Net income per share – diluted	$	0.04		$	0.04		$	0.11		$	0.01
		2013 Quarters Ended
		31-Mar			30-Jun			30-Sep			31-Dec
	Revenue	$	4,979		$	4,427		$	4,314		$	5,637
	Operating income		2,982			543			1,039			754
	Income from continuing operations		1,972			465			790			525
	Income (loss) from discontinued operations		(115	)		(158	)		(1,943	)		1,060
	Net income (loss)		1,857			307			(1,153	)		1,585
	Net income (loss) per share – basic	$	0.08		$	0.01		$	(0.05	)	$	0.07
	Net income (loss) per share – diluted	$	0.08		$	0.01		$	(0.05	)	$	0.07
	Quarterly amounts may not sum to annual amounts due to rounding and dilution.

OFFBALANCE_SHEET_ARRANGEMENTS

OFF-BALANCE SHEET ARRANGEMENTS	12 Months Ended
	Dec. 31, 2014
Off Balance Sheet Arrangements [Abstract]
OFF-BALANCE SHEET ARRANGEMENTS	15.      OFF-BALANCE SHEET ARRANGEMENTS
	We do not currently have any arrangements with unconsolidated entities, such as entities often referred to as structured finance, special purpose entities, or variable interest entities which are often established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.  Accordingly, we are not exposed to any financing, liquidity, market or credit risk if we had such relationships.
	In 2011 and 2012, we disclosed that we had a patent arrangement with an unaffiliated third party that we classified as a variable interest entity (“VIE”).  Under this arrangement we assigned certain patents to the third party, and the third party engages in monetization activities and shares royalties with us.  The third party is engaged in the business of the monetization of intellectual property. We continue to have a contractual relationship with this third party.
	We also disclosed in 2011 and 2012 that: i) we had no equity interest in the entity; ii) we were not contractually obligated to fund the entity, therefore our maximum exposure to loss as a result of our involvement with the entity was zero; iii) we may receive royalties in the future if certain conditions are met; iv) we were not the primary beneficiary of the entity; v) we had not consolidated the entity’s results into our financial statements, therefore we carried the assets and liabilities of this entity in our balance sheet at zero; and vi) prior to September 30, 2012, this arrangement had no impact on our results of operations, financial position or cash flows in any previous periods.
	We determined that the third party entity was a VIE in 2011 and 2012, because we made a judgment that the arrangement met two conditions under ASC 810 that caused VIE classification, namely: i) our right to receive royalties entitled us to receive a portion of the entity’s expected residual returns; and ii) a provision in the agreement denied the equity holders of the third party entity the power to direct the activities that most significantly impacted the entity’s economic performance.
	We also determined at that time that we were not the primary beneficiary because: i) we had no equity interest in the third party entity; and ii) a provision in the agreement resulted in “shared power” that did not give either party the power to direct the activities that most significantly impacted the economic performance of the entity.  Accordingly, we were not required to consolidate the third party entity under ASC 810, because we were not the primary beneficiary.
	Due to strategic legal reasons, we found it necessary to amend the agreement in August 2012 to eliminate the provision that had previously denied the equity holders of the third party entity the power to direct the activities that most significantly impacted the entity’s economic performance.  Upon amendment, the equity holders of the entity had such power, and we determined that the arrangement was no longer a VIE under ASC 810.

Schedule_of_valuation_and_qual

Schedule of valuation and qualifying accounts	12 Months Ended
	Dec. 31, 2014
Valuation and Qualifying Accounts [Abstract]
Schedule of valuation and qualifying accounts
	Schedule II - Valuation and Qualifying Accounts – Years ended December 31, 2014, 2013, and 2012
	(in thousands)
	Col. A	Col. B		Col. C(1)		Col. C(2)		Col. D		Col. E
				Additions
		Balance at		Charged to		Charged		Deductions		Balance
		Beginning		Costs and		to Other		Charged to		at End
		of Period		Expenses		Accounts		Reserves		of Period
	Allowance for doubtful accounts receivable:
	2014	$	20	$	-	$	-	$	-	$	20
	2013	$	20	$	-	$	-	$	-	$	20
	2012	$	30	$	-	$	-	$	10	$	20
	Inventory reserves:
	2014	$	-	$	-	$	-	$	-	$	-
	2013	$	-	$	-	$	-	$	-	$	-
	2012	$	1,403	$	126	$	-	$	1,529	$	-
	Warranty reserves:
	2014	$	-	$	-	$	-	$	-	$	-
	2013	$	10	$	-	$	-	$	10	$	-
	2012	$	-	$	12	$	-	$	2	$	10
	Deferred tax asset valuation allowance:
	2014	$	-	$	-	$	-	$	-	$	-
	2013	$	-	$	-	$	-	$	-	$	-
	2012	$	40,476	$	-	$	-	$	40,476	$	-

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation - The consolidated financial statements include the accounts of Aware, Inc. and its subsidiary (“the Company”).  All significant intercompany transactions have been eliminated.

Use of Estimates

Use of Estimates – The preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period.  The most significant estimates included in the financial statements pertain to revenue recognition, reserves for doubtful accounts, useful lives of fixed assets, valuation allowance for deferred income tax assets, and accrued liabilities.  Actual results could differ from those estimates.

Fair Value Measurements

Fair Value Measurements - The Financial Accounting Standards Board (“FASB”) Codification defines fair value, and establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to the unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of the fair value hierarchy under the FASB Codification are: i) Level 1 – valuations that are based on quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date; ii) Level 2 – valuations that are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly; and iii) Level 3 – valuations that require inputs that are both significant to the fair value measurement and unobservable.

Cash and cash equivalents, which primarily include money market mutual funds, were $44.0 million and $72.7 million as of December 31, 2014 and December 31, 2013, respectively. We classified our cash equivalents of $34.3 million and $68.6 million as of December 31, 2014 and 2013, respectively, within Level 1 of the fair value hierarchy because they are valued using quoted market prices.

Our investments, which consist of high yield corporate debt securities, are also classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. Debt securities with maturities greater than one year are classified as long term assets. We categorize our investments as available-for-sale securities, and carry them at fair value in our financial statements.  We had $1.4 million and $2.8 million of available-for-sale investments as of December 31, 2014 and December 31, 2013, respectively.

As of December 31, 2014, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands):

Fair Value Measurement at December 31, 2014 Using:

Quoted Prices in

Significant Other

Significant Unobservable

Active Markets for

Observable Inputs

Inputs

Identical Assets

(Level 1)

(Level 2)

(Level 3)

Corporate debt securities

$

1,428

$

-

$

-

Money market funds (included in cash and cash equivalents)

34,339

Total

$

35,767

$

-

$

-

Fair Value Measurement at December 31, 2013 Using:

Quoted Prices in

Significant Unobservable

Active Markets for

Significant Other

Inputs

Identical Assets

Observable Inputs

(Level 1)

(Level 2)

(Level 3)

Corporate debt securities

$

2,754

$

-

$

-

Money market funds (included in cash and cash equivalents)

68,556

Total

$

71,310

$

-

$

-

Cash and Cash Equivalents

Cash and Cash Equivalents – Cash and cash equivalents, which consist primarily of money market funds and demand deposits, are stated at fair value. All highly liquid investments purchased with an original maturity of three months or less are considered cash equivalents. Our cash balances exceed the Federal Deposit Insurance Corporation limits. The Company does not believe it is exposed to significant credit risk related to cash and cash equivalents.

Investments

Investments - At December 31, 2014 and 2013, we categorized all investment securities as available-for-sale, since we may liquidate these investments currently.  In calculating realized gains and losses, cost is determined using specific identification. Unrealized gains and losses on available-for-sale securities are excluded from earnings and reported in a separate component of stockholders’ equity called Accumulated Comprehensive Income.

Realized losses on investments were $59,000 in the year ended December 31, 2014. Realized gains on investments were $23,000 and $85,000 in the years ended December 31, 2013 and 2012, respectively.

Unrealized gains on investments were $162,000 in the year ended December 31, 2014. Unrealized losses on investments were $156,000, and $30,000 in the years ended December 31, 2013, and 2012.

The amortized cost of our corporate debt securities was $1.5 million at December 31, 2014. Corporate debt securities comprising investments mature in 2017 and 2018.

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts – Accounts are charged to the allowance for doubtful accounts as they are deemed uncollectible based on a periodic review of the accounts.

Inventories

Inventories – Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out (“FIFO”) method.  We evaluate all inventories for net realizable value on a quarterly basis, and record provisions for excess and obsolete inventory when required.  There was no reserve for excess and obsolete inventory as of December 31, 2014.

Property and Equipment

Property and Equipment – Property and equipment is stated at cost.  Depreciation and amortization of property and equipment is provided using the straight-line method over the estimated useful lives of the assets. Upon retirement or sale, the costs of the assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain or loss on disposal is included in the determination of income or loss.  Expenditures for repairs and maintenance are charged to expense as incurred.

The estimated useful lives of assets used by us are:

Building

30 years

Building improvements

5 to 20 years

Furniture and fixtures

5 years

Computer, office & manufacturing equipment

3 years

Purchased software

3 years

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets – We review long-lived assets for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate.  Each impairment test is based on a comparison of the undiscounted cash flows estimated to be generated by those assets over their estimated economic life to the related carrying value of those assets to determine if the assets are impaired. If an impairment is indicated, the asset is written down to its estimated fair value.  The cash flow estimates used to identify the potential impairment reflect our best estimates using appropriate assumptions and projections at that time.  We believe that no significant impairment of our long-lived assets has occurred as of December 31, 2014 and 2013.

Revenue Recognition

Revenue Recognition – We recognize revenue when there is persuasive evidence of an arrangement, the sales price is fixed or determinable, collection of the related receivable is reasonably assured, and delivery has occurred or services have been rendered.

Persuasive evidence of an arrangement: We use contracts signed by both the customer and us or written purchase orders issued by the customer as evidence of an arrangement.

Product delivery: We deem delivery to have occurred: (i) upon shipment when products are shipped FOB shipping point, or (ii) upon delivery at a customer’s location when products are shipped FOB destination, or (iii) when software is delivered electronically.  If customer acceptance provisions apply, revenue is not recognized until delivery has occurred and we have received such acceptance. If we are required to provide installation services, revenue is not recognized until installation is complete.

Fixed or determinable fee: We consider fees to be fixed or determinable if the fee is not subject to refund or adjustment and the payment terms are within normal established practices. If the fee is not fixed or determinable, we recognize the revenue as amounts become due and payable.

Collection is deemed probable: We conduct a credit review for significant transactions at the time of the arrangement to determine the credit-worthiness of the customer. Collection is deemed probable if we expect that the customer will pay amounts under the arrangement as payments become due.

We categorize revenue as software licenses, software maintenance, services, hardware, or royalties. In addition to the general revenue recognition policies described above, specific revenue recognition policies apply to each category of revenue.

Software licenses

Software licenses consist of revenue from the sale of software licenses for biometrics and imaging applications.  Our software licenses typically provide customers with the right to use our software in perpetuity.  We recognize revenue from software licenses upon delivery when licenses are sold in single element arrangements, because we have no post-delivery obligations, including contractual or implied Post Contract Support (“PCS”).

Software maintenance

Software maintenance consists of revenue from the sale of software maintenance contracts for biometrics and imaging software.  Software maintenance contracts entitle customers to receive software support and software updates, if and when they become available, during the term of the maintenance contract. We recognize software maintenance revenue ratably over the related contract period.

Services

Service revenue consists of fees from biometrics customers for software engineering services we provide to them. We recognize services revenue as services are delivered when services are sold in single element arrangements.

Hardware

Hardware revenue consists of sales of biometrics equipment to a single U.S. government customer.  We recognize hardware revenue upon delivery and acceptance of the equipment by the customer.

Royalties

Royalties consist primarily of royalty payments we receive under DSL silicon contracts with two customers that incorporate our silicon intellectual property (“IP”) in their DSL chipsets.  We sold the assets of our DSL IP business in 2009, but we continue to receive royalty payments from these customers.  Royalties are reported in continuing operations in accordance with ASC 205, Reporting Discontinued Operations, because we have continuing ongoing cash flows from this business.

Since we cannot reasonably estimate royalty revenue, such revenue is recognized in the quarter in which a final report is received from a customer. Royalty reports are typically received in the quarter immediately following the quarter in which sales of royalty-bearing products occur.

Multiple element arrangements with software and software related elements

In addition to selling software licenses, software maintenance and software services in single element arrangements, we also sell these three products as part of multiple element arrangements.  We apply the provisions of ASC 985-605, Software Revenue Recognition, to these arrangements because all the elements are software or software related.  The various combinations of multiple element arrangements and our revenue recognition for each are described as follows:

●

Software licenses and software maintenance. When software licenses and software maintenance contracts are sold together, we recognize software license revenue upon delivery, provided we have vendor specific objective evidence (“VSOE”) for the fair value of the maintenance contract fee, and we recognize the fair value of maintenance contract revenue ratably over the related contract period. Under ASC 985-605, the residual method is the appropriate manner in which to allocate arrangement consideration to the license when VSOE exists for all undelivered elements (e.g., PCS), but not for the delivered element (e.g., the license).

●

Software licenses and services. When software licenses and software engineering services are sold together, the total fee is generally recognized by applying contract accounting. We have adopted the percentage-of-completion method of contract accounting, and we generally use an input method (i.e., labor hours) to determine our completion percentage. The software license portion of the arrangement is classified as software license revenue and the engineering services portion is classified as services revenue in our consolidated statements of income and comprehensive income.

●

Software licenses, software maintenance and services. When we sell software licenses, software maintenance and software services together, revenue is recognized as follows: i) software maintenance revenue is separated from the other two elements and is recognized ratably over the related software maintenance contract period; provided we have VSOE for the fair value of the maintenance element; and ii) the total fee from the software license and engineering service elements is recognized by applying the contract accounting method described in the previous paragraph.

Multiple element arrangement with hardware and software elements

We also have a multiple element arrangement with one customer that involves the delivery of hardware, software maintenance, and software services.  We determined that these elements qualified as separate units of accounting under ASC 605, Revenue Recognition, because they have value to the customer on a standalone basis.  We recognize revenue from this arrangement as follows: i) hardware revenue is recognized upon delivery and acceptance of the equipment by the customer; ii) maintenance revenue is recognized ratably over the related contract period; and iii) service revenue is recognized as services are delivered.

Income Taxes

Income Taxes – We compute deferred income taxes based on the differences between the financial statement and tax basis of assets and liabilities using enacted rates in effect in the years in which the differences are expected to reverse.  We establish a valuation allowance to offset temporary deductible differences, net operating loss carryforwards and tax credits when it is more likely than not that the deferred tax assets will not be realized.

We recognize the tax benefit from an uncertain tax position only if it is more-likely-than-not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the tax position. The evaluation of an uncertain tax position is based on factors that include, but are not limited to, changes in the tax law, the measurement of tax positions taken or expected to be taken in tax returns, the effective settlement of matters subject to audit, and changes in facts or circumstances related to a tax position.  Any changes to these estimates, based on the actual results obtained and/or a change in assumptions, could impact our tax provision in future periods.  Interest and penalty charges, if any, related to unrecognized tax benefits would be classified as a provision for income tax in the statement of income.

Capitalization of Software Costs

Capitalization of Software Costs – We capitalize certain internally developed software development costs after technological feasibility of the product has been established.  No software costs were capitalized for the years ended December 31, 2014, 2013 and 2012, because such costs incurred subsequent to the establishment of technological feasibility, but prior to commercial availability, were immaterial.

Research and Development Costs

Research and Development Costs – Costs incurred in the research and development of our products are expensed as incurred.

Concentration of Credit Risk

Concentration of Credit Risk – At December 31, 2014 and 2013, we had cash and cash equivalents, in excess of federally insured deposit limits of approximately $43.7 million and $72.4 million, respectively.

Concentration of credit risk with respect to net accounts receivable consisted of amounts owed by the following customers that comprised more than 10% of net accounts receivable at December 31:

2014

2013

Customer A

18

%

60

%

Customer B

15

%

-

%

Customer C

11

%

-

%

Concentration of credit risk with respect to our investment portfolio consisted of $0.5 million, $0.5 million, and $0.4 million with three issuers of corporate debt securities, respectively, at December 31, 2014, and $0.8 million, $0.5 million, $0.5 million, $0.5 million, and $0.4 million with five issuers of corporate debt securities, respectively, at December 31, 2013.

Stock-Based Compensation

Stock-Based Compensation – We grant stock and stock options to our employees and directors.  We measure stock-based compensation cost at the grant date based on the fair value of the award and recognize stock-based compensation expense on a straight-line basis over the requisite service period of the award.

For stock awards, we determine the fair value of the award by using the fair market value of our stock on the date of grant; provided the number of shares in the grant is fixed on the grant date.

For stock options, we use the Black-Scholes option valuation model to estimate the fair value of the award. This valuation model takes into account the exercise price of the award, as well as a variety of significant assumptions.  The assumptions used to estimate the fair value of stock options include the expected term, the expected volatility of our stock over the expected term, the risk-free interest rate over the expected term, and our expected annual dividend yield.

Computation of Earnings per Share

Computation of Earnings per Share – Basic earnings per share is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding.  Diluted earnings per share is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding plus additional common shares that would have been outstanding if dilutive potential common shares had been issued.  For the purposes of this calculation, stock options are considered common stock equivalents in periods in which they have a dilutive effect.  Stock options that are antidilutive are excluded from the calculation.

Fair Value of Financial Instruments

Fair Value of Financial Instruments – The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value because of their short-term nature. The carrying amount of investments is based on the fair value of the individual securities in our investment portfolio.

Advertising Costs

Advertising Costs – Advertising costs are expensed as incurred and were not material for 2014, 2013, and 2012.

Recent Accounting Pronouncements

Recent Accounting Pronouncements – In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). The ASU is the result of a joint project by the FASB and the International Accounting Standards Board (“IASB”) to clarify the principles for recognizing revenue and to develop a common revenue standard for GAAP and International Financial Reporting Standards (“IFRS”) that would: remove inconsistencies and weaknesses, provide a more robust framework for addressing revenue issues, improve comparability of revenue recognition practices across entities, jurisdictions, industries, and capital markets, improve disclosure requirements and resulting financial statements, and simplify the presentation of financial statements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU is effective for annual reporting periods beginning after December 15, 2016.  Early adoption is not permitted. We are currently evaluating the effect that the updated standard will have on our consolidated financial statements and related disclosures.

With the exception of the new revenue standard discussed above, there have been no other recently issued accounting pronouncements that are of significance or potential significance to us that we have not adopted as of December 31, 2014.

Reclassifications

Reclassifications - Certain prior period amounts have been reclassified to be consistent with the current period presentation.

Segments

Segments – We organize ourselves into a single segment reporting to the chief operating decision makers. We have sales outside of the United States, which are described in Note 10.  All long-lived assets are maintained in the United States.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Schedule of assets measured at fair value on a recurring basis			Fair Value Measurement at December 31, 2014 Using:
			Quoted Prices in				Significant Other				Significant Unobservable
			Active Markets for				Observable Inputs				Inputs
			Identical Assets
			(Level 1)				(Level 2)				(Level 3)
	Corporate debt securities		$	1,428			$	-			$	-
	Money market funds (included in cash and cash equivalents)			34,339
	Total		$	35,767			$	-			$	-
			Fair Value Measurement at December 31, 2013 Using:
			Quoted Prices in								Significant Unobservable
			Active Markets for				Significant Other				Inputs
			Identical Assets				Observable Inputs
			(Level 1)				(Level 2)				(Level 3)
	Corporate debt securities		$	2,754			$	-			$	-
	Money market funds (included in cash and cash equivalents)			68,556
	Total		$	71,310			$	-			$	-
Schedule of estimated useful lives assets
	The estimated useful lives of assets used by us are:
	Building	30 years
	Building improvements	5 to 20 years
	Furniture and fixtures	5 years
	Computer, office & manufacturing equipment	3 years
	Purchased software	3 years
Schedules of concentration of credit risk with respect to net accounts receivable				2014				2013
		Customer A			18	%			60	%
		Customer B			15	%			-	%
		Customer C			11	%			-	%

DISCONTINUED_OPERATIONS_Tables

DISCONTINUED OPERATIONS (Tables)	12 Months Ended
	Dec. 31, 2014
Discontinued Operations and Disposal Groups [Abstract]
Schedule of income (loss) from discontinued operations attributable to the DSL service assurance segment		Years ended December 31,
		2014		2013			2012
	Revenue	$	-	$	3,216		$	5,431
	Expenses		-		5,120			5,558
	Loss before income taxes		-		(1,904	)		(127	)
	Income tax benefit		-		(748	)		(51	)
	Loss from discontinued operations	$	-	($	1,156	)	($	76	)

INVENTORIES_Tables

INVENTORIES (Tables)	12 Months Ended
	Dec. 31, 2014
Inventory Disclosure [Abstract]
Schedule of inventories		2014		2013
	Raw materials	$	2	$	1,584
	Finished goods		-		17
	Total	$	2	$	1,601

PROPERTY_AND_EQUIPMENT_Tables

PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Schedule of property and equipment		2014			2013
	Land	$	1,056		$	1,056
	Building and improvements		9,060			9,060
	Computer equipment		614			557
	Purchased software		78			88
	Furniture and fixtures		778			778
	Office equipment		191			191
	Total		11,777			11,730
	Less accumulated depreciation and amortization		(6,488	)		(6,148	)
	Property and equipment, net	$	5,289		$	5,582

INCOME_TAXES_Tables

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of components of the provision for income taxes
		Year ended December 31,
		2014			2013			2012
	Current:
	Federal	$	1,976		$	1,000		$	20,654
	State		589			273			1,594
			2,565			1,273			22,248
	Deferred:
	Federal		93			471			(1,354	)
	State		14			173			(407	)
			107			644			(1,761	)
	Total provision for income taxes	$	2,672		$	1,917		$	20,487
Schedule of reconciliation of the U.S. federal statutory rate to the effective tax rate
		Year ended December 31,
		2014			2013			2012
	Federal statutory rate		34	%		34	%		35	%
	State rate, net of federal benefit		5			5			5
	Tax credits		(1	)		(2	)		-
	Permanent adjustments		(1	)		(1	)		-
	Change in valuation allowance		-			-			(18	)
	Prior year adjustment		-			(2	)		-
	Effective tax rate		37	%		34	%		22	%
Schedule of components of deferred tax assets
		2014			2013
	Depreciation	$	374		$	418
	Stock compensation		303			199
	Capitalized research and development costs		96			364
	Other		199			164
	Total		972			1,145
	Less valuation allowance		(-	)		(-	)
	Deferred tax assets, net	$	972		$	1,145
Schedule of rollforward of the uncertain tax position related to research and development tax credits
	Uncertain tax positions at December 31, 2011	$	-
	Increase due to positions taken in prior periods		2,945
	Uncertain tax positions at December 31, 2012	$	2,945
	Increase due to positions taken in prior periods		-
	Uncertain tax positions at December 31, 2013	$	2,945
	Increase due to positions taken in prior periods		-
	Uncertain tax positions at December 31, 2014	$	2,945

EQUITY_AND_STOCK_COMPENSATION_1

EQUITY AND STOCK COMPENSATION PLANS (Tables)	12 Months Ended
	Dec. 31, 2014
Shareholders Equity and Share Based Payments [Abstract]
Schedule of stock-based employee compensation expense included in consolidated statements of income and comprehensive income		Years ended December 31,
		2014			2013		2012
	Cost of services	$	44		$	34	$	16
	Research and development		106			81		51
	Selling and marketing		17			14		126
	General and administrative		748			533		83
	Loss from discontinued operations		-			-		45
	Stock-based compensation expense	$	915		$	662	$	321
Schedule of assumption used to determine the fair value of options granted		Year Ended
		31-Dec-12
	Expected term (1)	5 years
	Expected volatility factor (2)		58-63	%
	Risk-free interest rate (3)		0.92	%
	Expected annual dividend yield		n/a
	(1) The expected term for each grant was determined based on the contractual term of the option.
	(2) The expected volatility for each grant is estimated based on an average of historical volatility over a period of time which we believe to be representative of our future volatility.
Schedule of the summary of stock option transactions for two fixed stock option plans
		2014					2013					2012
					Weighted					Weighted					Weighted
					Average					Average					Average
		Shares			Exercise		Shares			Exercise		Shares			Exercise
					Price					Price					Price
	Outstanding at beginning of year		1,004,989		$	5.68		1,063,025		$	5.63		2,835,952		$	4.42
	Granted		-			-		-			-		50,000			4.6
	Exercised		(117,783	)		3.98		(6,163	)		4.27		(1,779,616	)		3.71
	Forfeited or cancelled		(781,004	)		6.07		(51,873	)		4.83		(43,311	)		4.33
	Outstanding at end of year		106,202		$	4.71		1,004,989		$	5.68		1,063,025		$	5.63
	Exercisable at year end		104,117		$	4.69		986,237		$	5.7		1,027,525		$	5.66
Schedule of the summary of stock options outstanding
		Options Outstanding								Options Exercisable
	Exercise Price	Number			Weighted					Number		Weighted
	Range				Average		Weighted Average					Average
					Exercise		Remaining					Exercise
					Price		Contractual					Price
							Term (in years)
	$2 to $3		18,000		$	2.52		4.39			18,000	$	2.52
	$3 to $4		14,168			3.57		2.82			14,168		3.57
	$4 to $5		33,200			4.64		2.93			33,200		4.64
	$6 to $7		40,834			6.14		1.27			38,749		6.14
			106,202		$	4.71		2.52			104,117	$	4.69

BUSINESS_SEGMENTS_AND_MAJOR_CU1

BUSINESS SEGMENTS AND MAJOR CUSTOMERS (Tables)	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Schedule of revenues generated from geographic regions		Year ended December 31,
		2014			2013			2012
	United States	$	18,168		$	13,909		$	12,158
	Rest of world		5,552			5,448			5,146
		$	23,720		$	19,357		$	17,304
Schedule of revenue by product group		Year ended December 31,
		2014			2013			2012
	Biometrics	$	21,436		$	17,085		$	13,493
	Imaging		1,558			1,352			1,641
	DSL royalties		726			920			2,170
		$	23,720		$	19,357		$	17,304
Schedule of total revenue that was derived from major customers
		Year ended December 31,
		2014			2013			2012
	Customer A		24	%		21	%		5	%
	Customer B		10	%		3	%		-	%

NET_INCOME_PER_SHARE_Tables

NET INCOME PER SHARE (Tables)	12 Months Ended
	Dec. 31, 2014
Earnings Per Share [Abstract]
Schedule of net income per share
		Year ended December 31,
		2014		2013			2012
	Net income:
	Income from continuing operations	$	4,583	$	3,752		$	72,383
	Loss from discontinued operations		-		(1,156	)		(76	)
	Net income	$	4,583	$	2,596		$	72,307
	Shares outstanding:
	Weighted-average common shares outstanding		22,703		22,543			21,814
	Additional dilutive common stock equivalents		84		98			257
	Diluted shares outstanding		22,787		22,641			22,071
	Basic net income per share:
	Basic net income per share from continuing operations	$	0.2	$	0.17		$	3.32
	Basic net loss per share from discontinued operations		-		(0.05	)		(0.00	)
	Basic net income per share	$	0.2	$	0.12		$	3.32
	Diluted net income per share:
	Diluted net income per share from continuing operations	$	0.2	$	0.16		$	3.28
	Diluted net loss per share from discontinued operations		-		(0.05	)		(0.00	)
	Diluted net income per share	$	0.2	$	0.11		$	3.28

ACCUMULATED_OTHER_COMPREHENSIV1

ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)	12 Months Ended
	Dec. 31, 2014
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of accumulated other comprehensive loss and activity
			December 31,			Increase/			Reclassification			December 31,
			2013			Decrease			Adjustments			2014
	Unrealized losses on available for sale securities		($	206	)	$	60		$	59		($	87	)
	Unrealized gains on available for sale securities			-			43			-			43
	Net unrealized gains (losses) on available for sale securities			(206	)		103			59	(a)		(44	)
	Income tax benefit (expense) on other comprehensive loss			81			(46	)		(20	)		15
	Total accumulated other comprehensive loss, net of taxes		($	125	)	$	57		$	39		($	29	)
	(a)	– Classified in other expense.

QUARTERLY_RESULTS_OF_OPERATION1

QUARTERLY RESULTS OF OPERATIONS UNAUDITED (Tables)	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Schedule of quarterly financial information
		2014 Quarters Ended
		31-Mar			30-Jun			30-Sep			31-Dec
	Revenue	$	6,617		$	6,767		$	6,027		$	4,309
	Operating income		1,311			1,382			4,155			243
	Income from continuing operations		880			865			2,599			239
	Income from discontinued operations		-			-			-			-
	Net income		880			865			2,599			239
	Net income per share – basic	$	0.04		$	0.04		$	0.11		$	0.01
	Net income per share – diluted	$	0.04		$	0.04		$	0.11		$	0.01
		2013 Quarters Ended
		31-Mar			30-Jun			30-Sep			31-Dec
	Revenue	$	4,979		$	4,427		$	4,314		$	5,637
	Operating income		2,982			543			1,039			754
	Income from continuing operations		1,972			465			790			525
	Income (loss) from discontinued operations		(115	)		(158	)		(1,943	)		1,060
	Net income (loss)		1,857			307			(1,153	)		1,585
	Net income (loss) per share – basic	$	0.08		$	0.01		$	(0.05	)	$	0.07
	Net income (loss) per share – diluted	$	0.08		$	0.01		$	(0.05	)	$	0.07

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Assets measured at fair value on recurring basis (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1)
Schedule of Available-for-sale Securities [Line Items]
Investments, stated at fair value	$35,767	$71,310
Corporate debt securities | Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair value on recurring basis
Schedule of Available-for-sale Securities [Line Items]
Investments, stated at fair value	1,428	2,754
Corporate debt securities | Fair Value Measurement, Significant Other Observable Inputs (Level 2) | Fair value on recurring basis
Schedule of Available-for-sale Securities [Line Items]
Investments, stated at fair value
Corporate debt securities | Fair Value Measurement, Significant Unobservable Inputs (Level 3) | Fair value on recurring basis
Schedule of Available-for-sale Securities [Line Items]
Investments, stated at fair value
Money market funds (included in cash and cash equivalents) | Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1) | Fair value on recurring basis
Schedule of Available-for-sale Securities [Line Items]
Investments, stated at fair value	34,339	68,556
Money market funds (included in cash and cash equivalents) | Fair Value Measurement, Significant Other Observable Inputs (Level 2) | Fair value on recurring basis
Schedule of Available-for-sale Securities [Line Items]
Investments, stated at fair value
Money market funds (included in cash and cash equivalents) | Fair Value Measurement, Significant Unobservable Inputs (Level 3) | Fair value on recurring basis
Schedule of Available-for-sale Securities [Line Items]
Investments, stated at fair value

SUMMARY_OF_SIGNIFICANT_ACCOUNT4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Estimated useful lives of assets (Details 1)	12 Months Ended
	Dec. 31, 2014
Building
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets	30 years
Building improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets	5 years
Building improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets	20 years
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets	5 years
Computer, office & manufacturing equipment
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets	3 years
Purchased software
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets	3 years

SUMMARY_OF_SIGNIFICANT_ACCOUNT5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration of credit risk (Details 2) (Accounts Receivable, Credit Concentration Risk)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Customer A
Concentration Risk [Line Items]
Concentration risk, percentage	18.00%	60.00%
Customer B
Concentration Risk [Line Items]
Concentration risk, percentage	15.00%
Customer C
Concentration Risk [Line Items]
Concentration risk, percentage	11.00%

SUMMARY_OF_SIGNIFICANT_ACCOUNT6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents, which primarily include money market funds	$43,985	$72,660	$71,074	$46,577
Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities fair value	35,767	71,310
Cash equivalents, which primarily include money market funds	34,339	68,556
Fair value on recurring basis | Corporate debt securities | Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities fair value	$1,428	$2,754

SUMMARY_OF_SIGNIFICANT_ACCOUNT7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals 1) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Accounting Policies [Abstract]
Realized gains (losses) on investments	($59,000)	$23,000	$85,000
Unrealized gain (loss) on securities	$162,000	($156,000)	($30,000)

SUMMARY_OF_SIGNIFICANT_ACCOUNT8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals 2) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Schedule of Available-for-sale Securities [Line Items]
Cash and cash equivalents, in excess of federally insured deposit limits	$43.70	$72.40
Corporate debt securities
Schedule of Available-for-sale Securities [Line Items]
Amortized cost corporate debt securities	$1.50

SUMMARY_OF_SIGNIFICANT_ACCOUNT9

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals 3) (Investment Portfolio, Credit Concentration Risk, Corporate debt securities, USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
	Issuer	Issuer
Concentration Risk [Line Items]
Number of issuer	3	5
Issuer One
Concentration Risk [Line Items]
Concentration of risk, Amount	0.5	0.8
Issuer Two
Concentration Risk [Line Items]
Concentration of risk, Amount	0.5	0.5
Issuer Three
Concentration Risk [Line Items]
Concentration of risk, Amount	0.4	0.5
Issuer Four
Concentration Risk [Line Items]
Concentration of risk, Amount		0.5
Issuer Five
Concentration Risk [Line Items]
Concentration of risk, Amount		0.4

PATENT_RELATED_INCOME_Detail_T

PATENT RELATED INCOME (Detail Textuals ) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Patent Related Income [Abstract]
Gain on sale of patent assets	$2,127,000		$86,394,000
Income from patent arrangement		780,000	1,121,000
Total Patent Related Income	$2,127,000	$780,000	$87,515,000

PATENT_RELATED_INCOME_Detail_T1

PATENT RELATED INCOME (Detail Textuals 1) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]
Gain on sale of patent assets	$2,127,000	$86,394,000
Wireless patent
Finite-Lived Intangible Assets [Line Items]
Sale of patent		75,000,000
Transaction cost		3,800,000
Gain on sale of patent assets		71,200,000
DSL patent
Finite-Lived Intangible Assets [Line Items]
Sale of patent	2,600,000	16,000,000
Transaction cost	500,000	800,000
Gain on sale of patent assets	$2,100,000	$15,200,000

DISCONTINUED_OPERATIONS_Income

DISCONTINUED OPERATIONS - Income (loss) from discontinued operations attributable to DSL service (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Income tax benefit									$700	$51
Loss from discontinued operations					1,060	-1,943	-158	-115	-1,156	-76
DSL Service Assurance
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue									3,216	5,431
Expenses									5,120	5,558
Loss before income taxes									-1,904	-127
Income tax benefit									-748	-51
Loss from discontinued operations									($1,156)	($76)

DISCONTINUED_OPERATIONS_Detail

DISCONTINUED OPERATIONS (Detail Textuals) (DSL Service Assurance, Discontinued Operations, USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Restructuring Cost and Reserve [Line Items]
Estimated shutdown cost		$2,900,000
Severance and employee related costs			300,000
Payment for severance cost	100,000
Asset write-offs		48,000
Employee Severance And Retention Bonus
Restructuring Cost and Reserve [Line Items]
Severance and employee related costs		300,000
Contract Termination
Restructuring Cost and Reserve [Line Items]
Deferred revenue obligations		1,200,000
Payments/write-offs		($3,700,000)

INVENTORIES_Summary_of_invento

INVENTORIES - Summary of inventories (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Inventory Disclosure [Abstract]
Raw materials	$2	$1,584
Finished goods		17
Total	$2	$1,601

PROPERTY_AND_EQUIPMENT_Summary

PROPERTY AND EQUIPMENT - Summary of property and equipment (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Public Utility, Property, Plant and Equipment [Line Items]
Total	$11,777	$11,730
Less accumulated depreciation and amortization	-6,488	-6,148
Property and equipment, net	5,289	5,582
Land
Public Utility, Property, Plant and Equipment [Line Items]
Total	1,056	1,056
Building and improvements
Public Utility, Property, Plant and Equipment [Line Items]
Total	9,060	9,060
Computer equipment
Public Utility, Property, Plant and Equipment [Line Items]
Total	614	557
Purchased software
Public Utility, Property, Plant and Equipment [Line Items]
Total	78	88
Furniture and fixtures
Public Utility, Property, Plant and Equipment [Line Items]
Total	778	778
Office equipment
Public Utility, Property, Plant and Equipment [Line Items]
Total	$191	$191

PROPERTY_AND_EQUIPMENT_Detail_

PROPERTY AND EQUIPMENT (Detail Textuals) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Abstract]
Depreciation expense	$0.40	$0.50	$0.40
Retired of assets	$0.10	$0.30	$1

INCOME_TAXES_Components_of_pro

INCOME TAXES - Components of provision for income taxes (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Current:
Federal	$1,976	$1,000	$20,654
State	589	273	1,594
Total current tax	2,565	1,273	22,248
Deferred:
Federal	93	471	-1,354
State	14	173	-407
Total deferred tax	107	644	-1,761
Total provision for income taxes	$2,672	$1,917	$20,487

INCOME_TAXES_Reconciliation_of

INCOME TAXES - Reconciliation of U.S. federal statutory rate (Details 1)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Federal statutory rate	34.00%	34.00%	35.00%
State rate, net of federal benefit	5.00%	5.00%	5.00%
Tax credits	-1.00%	-2.00%
Permanent adjustments	-1.00%	-1.00%
Change in valuation allowance			-18.00%
Prior year adjustment		-2.00%
Effective tax rate	37.00%	34.00%	22.00%

INCOME_TAXES_Principal_compone

INCOME TAXES - Principal components of deferred tax assets (Details 2) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Income Tax Disclosure [Abstract]
Depreciation	$374	$418
Stock compensation	303	199
Capitalized research and development costs	96	364
Other	199	164
Total	972	1,145
Less valuation allowance
Deferred tax assets, net	$972	$1,145

INCOME_TAXES_Rollforward_of_un

INCOME TAXES - Rollforward of uncertain tax position (Details 3) (Research and development tax credits, USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Research and development tax credits
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Uncertain tax positions	$2,945	$2,945
Increase due to positions taken in prior periods			2,945
Uncertain tax positions	$2,945	$2,945	$2,945

INCOME_TAXES_Detail_Textuals

INCOME TAXES (Detail Textuals) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Provision for income taxes	$2,672,000	$1,917,000	$20,487,000
Total income tax expense	2,700,000	1,200,000	20,400,000
Income from continuing operations before income taxes	7,255,000	5,669,000	92,870,000
Income tax expense (benefit) from discontinuing operations		-700,000	-51,000
Actual tax liability			7,800,000
U.S. statutory rate	34.00%	34.00%	35.00%
Amount of reduction in currently payable of income tax expense			14,400,000
Amount of reduction in income tax expense			1,800,000
Federal credits written off			1,900,000
State credits written off			1,000,000
Uncertain tax positions	2,600,000
Net federal credit carryforwards related to excess stock compensation deductions	4,000,000
State research and development credit carryforwards related to excess stock compensation deductions	300,000
Tax benefit related to research tax credit			100,000
Reduction in estimate tax expense			100,000
Tax benefits from stock-based awards	$1,247,000	$128,000	$14,395,000

EQUITY_AND_STOCK_COMPENSATION_2

EQUITY AND STOCK COMPENSATION PLANS - Stock-based employee compensation expenses (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	$915,000	$662,000	$321,000
Cost of services
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	44,000	34,000	16,000
Research and development
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	106,000	81,000	51,000
Selling and marketing
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	17,000	14,000	126,000
General and administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	748,000	533,000	83,000
Loss from discontinued operations
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense			$45,000

EQUITY_AND_STOCK_COMPENSATION_3

EQUITY AND STOCK COMPENSATION PLANS - Assumptions used to determine fair value of options (Details 1) (Stock Options)	12 Months Ended
	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term	5 years	[1]
Risk-free interest rate	0.92%	[2]
Expected annual dividend yield
Fair value assumptions, method used	Black-Scholes valuation model
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility factor	63.00%	[3]
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility factor	58.00%	[3]
[1]	The expected term for each grant was determined based on the contractual term of the option.
[2]	The risk-free interest rate for each grant is based on the U.S. Treasury yield curve in effect at the time of grant for a period equal to the expected term of the stock option.
[3]	The expected volatility for each grant is estimated based on an average of historical volatility over a period of time which we believe to be representative of our future volatility.

EQUITY_AND_STOCK_COMPENSATION_4

EQUITY AND STOCK COMPENSATION PLANS - Summary of stock option transactions (Details 2) (Stock Option, USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Stock Option
Shares
Outstanding at beginning of year	1,004,989	1,063,025	2,835,952
Granted			50,000
Exercised	-117,783	-6,163	-1,779,616
Forfeited or cancelled	-781,004	-51,873	-43,311
Outstanding at end of year	106,202	1,004,989	1,063,025
Exercisable at year end	104,117	986,237	1,027,525
Weighted Average Exercise Price
Outstanding at beginning of year	$5.68	$5.63	$4.42
Granted			$4.60
Exercised	$3.98	$4.27	$3.71
Forfeited or cancelled	$6.07	$4.83	$4.33
Outstanding at end of year	$4.71	$5.68	$5.63
Exercisable at year end	$4.69	$5.70	$5.66

EQUITY_AND_STOCK_COMPENSATION_5

EQUITY AND STOCK COMPENSATION PLANS - Summarizes of stock options outstanding (Details 3) (Stock Option, USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding, Number	106,202	1,004,989	1,063,025	2,835,952
Options outstanding, Weighted average exercise price	$4.71	$5.68	$5.63	$4.42
Options outstanding, Weighted average remaining contractual term (in years)	2 years 6 months 7 days
Options exercisable, Number	104,117	986,237	1,027,525
Options exercisable, Weighted average exercise price	$4.69	$5.70	$5.66
Exercise price range $2 to $3
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range (lower)	$2
Exercise price range (upper)	$3
Options outstanding, Number	18,000
Options outstanding, Weighted average exercise price	$2.52
Options outstanding, Weighted average remaining contractual term (in years)	4 years 4 months 21 days
Options exercisable, Number	18,000
Options exercisable, Weighted average exercise price	$2.52
Exercise price range $3 to $4
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range (lower)	$3
Exercise price range (upper)	$4
Options outstanding, Number	14,168
Options outstanding, Weighted average exercise price	$3.57
Options outstanding, Weighted average remaining contractual term (in years)	2 years 9 months 26 days
Options exercisable, Number	14,168
Options exercisable, Weighted average exercise price	$3.57
Exercise price range $4 to $5
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range (lower)	$4
Exercise price range (upper)	$5
Options outstanding, Number	33,200
Options outstanding, Weighted average exercise price	$4.64
Options outstanding, Weighted average remaining contractual term (in years)	2 years 11 months 5 days
Options exercisable, Number	33,200
Options exercisable, Weighted average exercise price	$4.64
Exercise price range $6 to $7
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range (lower)	$6
Exercise price range (upper)	$7
Options outstanding, Number	40,834
Options outstanding, Weighted average exercise price	$6.14
Options outstanding, Weighted average remaining contractual term (in years)	1 year 3 months 7 days
Options exercisable, Number	38,749
Options exercisable, Weighted average exercise price	$6.14

EQUITY_AND_STOCK_COMPENSATION_6

EQUITY AND STOCK COMPENSATION PLANS (Detail Textuals) (Incentive stock options and nonqualified stock options)	12 Months Ended
	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Description of compensation arrangement by share based payment award vesting rights	Our options generally vest over three to five years.
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of options are granted at exercise prices	10 years
Term of options vested	5 years
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of options are granted at exercise prices	4 years
Term of options vested	3 years
Stock Option Plan 1996
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common stocks authorized to grant	6,100,000
Stock Option Plan 2001
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common stocks authorized to grant	8,000,000
Number of common stocks available for grant	5,062,381

EQUITY_AND_STOCK_COMPENSATION_7

EQUITY AND STOCK COMPENSATION PLANS (Detail Textuals 1) (USD $)	12 Months Ended			3 Months Ended	6 Months Ended	4 Months Ended	6 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2013	Dec. 31, 2013	Jun. 30, 2014	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$915,000	$662,000	$321,000
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number stock issued	0	0	50,000
Unrestricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number stock issued	152,000	130,000	0
Unrestricted Stock | April 2013 Grant | Directors, Officers and Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number stock issued		130,000
Stock-based compensation expense		623,000
Unrestricted Stock | April 2013 Grant | Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number stock issued		130,000		51,374	49,936
Number of common stock shares surrendered by employees withholding taxes				13,626	15,064
Common stock value surrendered by employees withholding taxes				71,000	92,000
Stock-based compensation expense		623,000
Unrestricted Stock | 2010 stock Grant
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number stock issued			118,113
Number of common stock shares surrendered by employees withholding taxes			33,441
Common stock value surrendered by employees withholding taxes			174,000
Stock-based compensation expense			189,000
Unrestricted Stock | March 2014 Grant | Directors, Officers and Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number stock issued	152,000
Stock-based compensation expense	876,000
Unrestricted Stock | March 2014 Grant | Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number stock issued						58,769	56,804
Number of common stock shares surrendered by employees withholding taxes						17,231	19,196
Common stock value surrendered by employees withholding taxes						$113,000	$87,000

EQUITY_AND_STOCK_COMPENSATION_8

EQUITY AND STOCK COMPENSATION PLANS (Detail Textuals 2) (Stock Options, USD $)	12 Months Ended
	Dec. 31, 2014
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options expected to vest	106,202
Weighted average exercise price of options expected to vest	$4.71
Weighted average grant date fair values exercise prices	$2.38
Weighted average remaining contractual term	2 years 6 months
Aggregate intrinsic value of options outstanding and exercisable out-of-the money	$0
Aggregate intrinsic value of options exercised during the year	301,000
Unrecognized compensation expense	$7,000
Period for recognized over a weighted average period	3 months

EQUITY_AND_STOCK_COMPENSATION_9

EQUITY AND STOCK COMPENSATION PLANS (Detail Textuals 3) (Employee Stock Purchase Plan)	1 Months Ended		12 Months Ended
	Nov. 29, 2005	Jun. 30, 1996	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of common stock at a price lower of the fair market value	95.00%	85.00%
Period of common stock offering	6 months	6 months
Minimal discount of fair market value of the common stock	5.00%
Percentage of employee's compensation	6.00%
Total Number of common stock Share reserved for issuance			350,000
Number of common stock Share reserved for issuance			100,937
Issuance of common stock under employee stock purchase plan (in shares)			8,022	7,196	4,661

Recovered_Sheet1

EQUITY AND STOCK COMPENSATION PLANS (Detail Textuals 4) (USD $)	1 Months Ended	0 Months Ended	1 Months Ended
In Millions, except Per Share data, unless otherwise specified	Jun. 26, 2014	Apr. 12, 2012	Nov. 30, 2012
Shareholders Equity and Share Based Payments [Abstract]
Special cash dividend declared date	26-Jun-14
Special cash dividends declared (in dollars per share)	$1.75	$1.15	$1.80
Special cash dividend payable date	24-Jul-14	25-May-12	17-Dec-12
Shareholders of record date	10-Jul-14	11-May-12	3-Dec-12
Dividends payable	$39.90	$25.50	$40.50

COMMITMENTS_AND_CONTINGENT_LIA1

COMMITMENTS AND CONTINGENT LIABILITIES (Detail Textuals ) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Commitments and Contingencies Disclosure [Abstract]
Rental expense	$0	$0	$25,000

BUSINESS_SEGMENTS_AND_MAJOR_CU2

BUSINESS SEGMENTS AND MAJOR CUSTOMERS - Revenues generated from geographic regions (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting Information [Line Items]
Revenue	$4,309	$6,027	$6,767	$6,617	$5,637	$4,314	$4,427	$4,979	$23,720	$19,357	$17,304
Operating Segments
Segment Reporting Information [Line Items]
Revenue									23,720	19,357	17,304
Operating Segments | United States
Segment Reporting Information [Line Items]
Revenue									18,168	13,909	12,158
Operating Segments | Rest of World
Segment Reporting Information [Line Items]
Revenue									$5,552	$5,448	$5,146

BUSINESS_SEGMENTS_AND_MAJOR_CU3

BUSINESS SEGMENTS AND MAJOR CUSTOMERS - Summary of revenue by product group (Details 1) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting Information [Line Items]
Revenue	$4,309	$6,027	$6,767	$6,617	$5,637	$4,314	$4,427	$4,979	$23,720	$19,357	$17,304
Operating Segments
Segment Reporting Information [Line Items]
Revenue									23,720	19,357	17,304
Operating Segments | Biometrics
Segment Reporting Information [Line Items]
Revenue									21,436	17,085	13,493
Operating Segments | Imaging
Segment Reporting Information [Line Items]
Revenue									1,558	1,352	1,641
Operating Segments | Dsl Royalties
Segment Reporting Information [Line Items]
Revenue									$726	$920	$2,170

BUSINESS_SEGMENTS_AND_MAJOR_CU4

BUSINESS SEGMENTS AND MAJOR CUSTOMERS - Revenue derived from major customers (Details 2) (Sales revenue)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Customer A
Revenue, Major Customer [Line Items]
Concentration risk, percentage	24.00%	21.00%	5.00%
Customer B
Revenue, Major Customer [Line Items]
Concentration risk, percentage	10.00%	3.00%

EMPLOYEE_BENEFIT_PLAN_Detail_T

EMPLOYEE BENEFIT PLAN (Detail Textuals) (Retirement Plans 401 K Defined Benefit, USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Retirement Plans 401 K Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Contribution by employer	$198,000	$189,000	$233,000

NET_INCOME_PER_SHARE_Calculati

NET INCOME PER SHARE - Calculation of net income per share (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Net income:
Income from continuing operations	$239	$2,599	$865	$880	$525	$790	$465	$1,972	$4,583	$3,752	$72,383
Loss from discontinued operation					1,060	-1,943	-158	-115		-1,156	-76
Net income	$239	$2,599	$865	$880	$1,585	($1,153)	$307	$1,857	$4,583	$2,596	$72,307
Shares outstanding:
Weighted-average common shares outstanding									22,703	22,543	21,814
Additional dilutive common stock equivalents									84	98	257
Diluted shares outstanding									22,787	22,641	22,071
Basic net income per share:
Basic net income per share from continuing operations (in dollars per share)									$0.20	$0.17	$3.32
Basic net loss per share from discontinued operations (in dollars per share)										($0.05)	$0
Basic net income per share (in dollars per share)	$0.01	$0.11	$0.04	$0.04	$0.07	($0.05)	$0.01	$0.08	$0.20	$0.12	$3.32
Diluted net income per share:
Diluted net income per share from continuing operations (in dollars per share)									$0.20	$0.16	$3.28
Diluted net loss per share from discontinued operations (in dollars per share)										($0.05)	$0
Diluted net income per share (in dollars per share)	$0.01	$0.11	$0.04	$0.04	$0.07	($0.05)	$0.01	$0.08	$0.20	$0.11	$3.28

NET_INCOME_PER_SHARE_Detail_Te

NET INCOME PER SHARE (Detail Textuals) (Stock Options, USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock share purchase (in shares)	40,834	823,338	821,838
Weighted average price of anti-dilutive options (in dollars per shares)	$6.14	$6.07	$6.07

ACCUMULATED_OTHER_COMPREHENSIV2

ACCUMULATED OTHER COMPREHENSIVE LOSS - Components of accumulated other comprehensive loss and activity (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance Net unrealized gains (losses) on available for sale securities	($206)
Beginning balance Income tax benefit (expense) on other comprehensive loss	81
Beginning balance Total accumulated other comprehensive loss, net of taxes	-125
Increase/Decrease Net unrealized gains (losses) on available for sale securities	103
Increase/Decrease Income tax benefit (expense) on other comprehensive loss	-46
Increase/Decrease Total accumulated other comprehensive loss, net of taxes	57
Reclassification Adjustments Net unrealized gains (losses) on available for sale securities	59	[1]
Reclassification Adjustments Income tax benefit (expense) on other comprehensive loss	-20
Reclassification Adjustments Total accumulated other comprehensive loss, net of taxes	39
Ending balance Net unrealized gains (losses) on available for sale securities	-44
Ending balance Income tax benefit (expense) on other comprehensive loss	15
Ending balance Total accumulated other comprehensive loss, net of taxes	-29
Unrealized losses on available for sale securities
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance Net unrealized gains (losses) on available for sale securities	-206
Increase/Decrease Net unrealized gains (losses) on available for sale securities	60
Reclassification Adjustments Net unrealized gains (losses) on available for sale securities	59
Ending balance Net unrealized gains (losses) on available for sale securities	-87
Unrealized gains on available for sale securities
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance Net unrealized gains (losses) on available for sale securities
Increase/Decrease Net unrealized gains (losses) on available for sale securities	43
Reclassification Adjustments Net unrealized gains (losses) on available for sale securities
Ending balance Net unrealized gains (losses) on available for sale securities	$43
[1]	Classified in other expense.

QUARTERLY_RESULTS_OF_OPERATION2

QUARTERLY RESULTS OF OPERATIONS - UNAUDITED - Summary of consolidated statements of comprehensive income (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Quarterly Financial Information Disclosure [Abstract]
Revenue	$4,309	$6,027	$6,767	$6,617	$5,637	$4,314	$4,427	$4,979	$23,720	$19,357	$17,304
Operating income	243	4,155	1,382	1,311	754	1,039	543	2,982
Income from continuing operations	239	2,599	865	880	525	790	465	1,972	4,583	3,752	72,383
Income (loss) from discontinued operations					1,060	-1,943	-158	-115		-1,156	-76
Net income (loss)	$239	$2,599	$865	$880	$1,585	($1,153)	$307	$1,857	$4,583	$2,596	$72,307
Net income (loss) per share - basic (in dollars per share)	$0.01	$0.11	$0.04	$0.04	$0.07	($0.05)	$0.01	$0.08	$0.20	$0.12	$3.32
Net income (loss) per share - diluted (in dollars per share)	$0.01	$0.11	$0.04	$0.04	$0.07	($0.05)	$0.01	$0.08	$0.20	$0.11	$3.28

Schedule_of_valuation_and_qual1

Schedule of valuation and qualifying accounts (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Allowance for doubtful accounts receivable
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at Beginning of Period	$20	$20	$30
Charged to Cost and Expense
Charged to Other Accounts
Deductions Charged to Reserves			10
Balance at End of Period	20	20	20
Inventory reserves
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at Beginning of Period			1,403
Charged to Cost and Expense			126
Charged to Other Accounts
Deductions Charged to Reserves			1,529
Balance at End of Period
Warranty reserves
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at Beginning of Period		10
Charged to Cost and Expense			12
Charged to Other Accounts
Deductions Charged to Reserves		10	2
Balance at End of Period			10
Deferred tax asset valuation allowance
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at Beginning of Period			40,476
Charged to Cost and Expense
Charged to Other Accounts
Deductions Charged to Reserves			40,476
Balance at End of Period